European
European
European
|e| o| Ceo||.e |e|||, oJ |e|oJo|o|o,. ||.e||, /eJ|co| e|e |e|o. |e|o. Oeo,.
2
||||o|e o| /eJ|co| ||oe|, oJ /eJ|co| ||oo||c. |e|o.
Oeo,
Objectives: The purpose of this study was to evaluate impact of three different manufacturing processes on tensile bond strength (TBS) and its durability.
Additionally, influence of two different resin luting materials on TBS was examined.
Methods: Y-TZP ceramic specimens were divided in three groups (n=48). In group 1 zirconia ceramic discs were industrially fabricated using ceramic injection
moulding (CIM, gapless, D), in group 2 specimens were milled with a Lava machine (L, 3M Espe, D) and subsequently sintered, and in group 3 specimens consisted of
hipped zirconia ceramic (DC-Zirkon, Metoxit, CH), and were milled after finishing the hip-treatment. Hollow plastic screws filled with composite resin were bonded to
the zirconia ceramic discs, half and half with a conventional composite resin (V, Variolink II) and with a phosphate monomer-containing resin (P, Panavia 21). TBS was
measured in a universal testing machine after 24 hours, and after 150 days aging in Ringer's solution. Failure modes were examined under magnification. ANOVA was
used to test the effects of the manufacturing processes, the luting materials and the aging procedure on bond strength. Multiple comparisons of least-square means
were done for the pair-wise comparisons adjusted by Tukey-Kramer.
Results: With both resins tested CIM ceramic revealed significantly higher TBS compared to the other tested ceramic materials. Using the conventional composite
resin, additionally L ceramic showed significantly higher TBS compared to DC ceramic. Mean bond strength values of 37.4MPa (1.7) and 33.9MPa (1.7) for P, and
36.1MPa (2.2) and 27.8MPa (2.2) for V were measured after 24h and after 150d, respectively. Influence of aging was significant for V only (p0.002). Fracture mode
was basically mixed cohesive/adhesive.
Conclusion: Tensile bond strength between zirconia ceramic and composite luting materials is influenced by the manufacturing process of the ceramic work piece,
and the luting material used.
0120 (151900)
Bonding effectiveness of luting composites to zirconia ceramics
M. INOKOSHI
1
, A. KAMEYAMA
1
, S. MINAKUCHI
2
, J. DE MUNCK
1
and B. VAN MEERBEEK
1
|eo.e ||C/^ |eeoc| |o|e. |eo|e| o| oe.o||.e |e|||,. o||o||c ||.e||, o| |eo.e. |eo.e. |e||o.
2
o|e|e |e|oe |o||oJo||c. o|,o /eJ|co|
|e|o| ||.e||,. o|,o. .oo
Bonding to dental zirconia ceramics has been shown to be challenging.
Objectives: To evaluate the effect of mechanical surface conditioning and artificial aging on the micro-tensile bond strength (TBS) of two dual-cure composite
cements to zirconia ceramics.
Methods: Fully sintered IPS e.max ZirCAD (Ivoclar-Vivadent) blocks were either (1) not pre-treated or (2) subjected to tribochemical silica coating (CoJet, 3M ESPE) for
2 sec (at a distance of about 10 mm). Next, the silane coupling agent Clearfil Ceramic Primer (Kuraray) was applied during 60 sec, followed by gentle air-drying, after
which two zirconia blocks were bonded together using one of two dual-cure composite cements (Panavia F2.0 or Clearfil Esthetic Cement, Kuraray). The specimens
were trimmed at the interface to a cylindrical hour-glass shape (diameter = about 1.2 mm). All specimens were stored for 7 days in distilled water at 37C, after which
they were randomly divided into 2 subgroups; half of the specimens were subjected to 10,000 thermocycles between 5 and 55C during 10 days; the other half were
further immersed in 37C water for 10 days (n=15-20 per group). After storage, the TBS was determined in MPa. Data were analyzed with Weibull, three-way ANOVA
and Turkey's test (P<0.05). Fractographic analysis was performed using SEM.
Results: Weibull analysis revealed the highest (scale-parameter of 54), most reliable (shape-parameter of 3.5) and least low (Blife significantly higher at 10%
unreliability) values for the CoJet-Panavia F2.0 group, thereby scoring significantly higher than any other group. Without tribochemical silica coating, the lowest TBS
was measured for Panavia F2.0 (Tukey, p<0.05). When Clearfil Esthetic cement was used, neither tribochemical silica coating, nor thermocycling influenced the TBS.
Conclusion: Mechanical surface conditioning using tribochemical silica coating appeared needed for Panavia F2.0 to effectively bond to zirconia ceramics, while not
for the more hydrophobic Clearfil Esthetic Cement.
0121 (152180)
Influence of Surface Treatments on Surface of Four Zirconia Ceramics
I. YONDEM
1
, M.T. YUCEL
1
, M. BULBUL
2
and A.N. OZTURK
3
|eo.e ||C/^ |eeoc| |o|e. |eo|e| o| oe.o||.e |e|||,. o||o||c ||.e||, o| |eo.e. |eo.e. |e||o.
2
|eo|ee| /|co|o|o|e oJ |oo|o|e.
o||o||c ||.e||, o| |eo.e. |eo.e. |e||o.
3
|oo.e /eJ|co| c|oo|. |oo.e. Oeo,
Many studies suggest that MMP-9 might be involved in degradation of resin-dentin interfaces.
Objective: To determine the effect of an activated MMP-solution on the mechanical properties of the bond to dentin. If MMP-9 is involved in the bond-degradation
process, the activated MMP-9 solution is expected to reduce the bond strength to dentin.
Methods: Bur-cut dentin surfaces of 6 human molars were etched with 37% phosphoric acid (Scotchbond Etchant, 3M ESPE) for 15 sec and rinsed with water for 10
sec. Half of the surface was treated with either a 0.1 M (MMP-LC) or 10 M MMP-9 solution (MMP-HC) in TRIS-buffer for 60 seconds, while the other half (buffer
treatment only) served as control. Then, the etch&rinse adhesive Scotchbond 1 XT (3M ESPE) was applied, followed by a composite (Z100, 3M ESPE) build-up. After
storage in water for 7 days at 37C, 1x1 mm resin-dentin sticks were prepared and the micro-tensile bond strength (TBS) was determined.
Results: One-way-ANOVA revealed no significant differences between the groups (p=0.8081). The mean TBS values were 48.4 8.6 MPa for group MMP-LC, 45.3
15.3 MPa for group MMP-HC and 44.9 14.3 MPa for the control. Failure analysis revealed predominantly mixed failures for all groups, including failures inside the
dentin, at the resin-dentin interface and inside the resin (adhesive/composite) part.
Conclusion: Application of a highly concentrated, activated MMP-9 solution did not affect the bonding effectiveness of a 2-step etch&rinse adhesive to dentin.
Therefore, the role of this gelatinase in bond degradation appears limited, as before the gelatinase can be involved, collagen fibrils need first to be broken down by
other degradation mechanisms.
0124 (151472)
Effect of HEMA on bonding efficiency of 10-MDP to hydroxyapatite
K. YOSHIHARA
1
, Y. YOSHIDA
2
, S. HAYAKAWA
2
, N. NAGAOKA
2
, K. VAN LANDUYT
1
, A. OSAKA
2
, K. SUZUKI
2
, S. MINAGI, and B. VAN MEERBEEK
1
||.||o o| eeo| Je|||,. |||co| ce|e o| ,c|ooo||c Je|||,. |e ||o |e|o| ||.e||, |o||o|. o|,o. .oo.
2
||.||o o| C||oJo||c. |e ||o |e|o|
||.e||, |o||o|. o|,o. .oo.
3
||o |e|o| ||.e||,. o|,o. .oo.
4
|e| o| |o||oJo||c. ||o |e|o| ||.e||,. |o|o||,. o|,o. .oo.
5
||.||o o| eeo|
Je|||,. |e ||o |e|o| ||.e||, |o||o|. o|,o. .oo
Objective: The Nippon Dental University Hospital is making efforts to develop systems simulating patients' feelings, and apply them to the education of dentists to
nurture holistic dentistry. We tried to improve the efficiency of interns' self-learning by adding new post-training feedback functions and clinical programs according
to various situations to the GUI (Graphical User Interface) for a patient simulation systems for dental education (SIMROID) developed in this project.
Methods: We upgraded the GUI, developed based on a survey on feelings during clinical programs using SIMROID in twenty doctors who had agreed on the
purpose of its development, by adding new post-training feedback functions usingMicrosoft Visual C++ 8.0 and clinical programs to encourage interns' self-
evaluation.
Results: As part of the feedback functions, the GUI is equipped with a video-recording function using an external camera during the training session, and a display
function of the entire history of actions (commands) with a touch pen issued for the patient robot. The latter allows the user to stop the movie at any time and print
the scene. Furthermore, training data can be collectively managed within the GUI by creating folders for individual interns. This function enables interns to easily
reflect on their own performance.
Conclusion: The upgrade of the GUI for the patient simulation system for dental education, together with the addition of the new feedback functions essential in
objective evaluation by instructors and self-evaluation by interns, will lead us to developSIMROID, a comprehensive simulation system, with which we can further
advance holistic dental education. [This study was subsidized by Japan science and technology agency as adevelopment of creative technology seeds]
0131 (152116)
Does visual acuity influence operative skills?
K.W. NEUHAUS, P. PERRIN, M. EMERICH, and A. LUSSI
||.e||, o| |e. |e. .||e|oJ
Objectives: The aim of this intervention study was to test if the visual acuity has in impact on operative skills with a dental bur.
Methods: Twenty-nine undergraduate students with half a year of phantom head training underwent a classical optical test at an optician. In the first run, the
students were instructed to prepare two different geometrical forms on acrylic blocks (A-PTS, Frasaco, Germany) mounted in phantom heads. In a second run two
weeks later the students repeated the same task but were provided with dental Galilean loupes (EyeMag, Zeiss; 2.5X magnification) that were individually adjusted.
Quality parameters included a) operative accuracy (Neuhaus et al. 2010), b) simple following of a line with a rotating diamond bur, c) preparation depth, and d)
preparation angles of a 3D-cavity. Students with an observed natural visus <1 were defined as bad viewers (Eichenberger et al. 2011)
Results: The use of dental loupes significantly enhanced the operative accuracy and preciseness of drilling. According to the optical test, two students were classified
37
as bad viewers. A significantly lower accuracy was found in the group of bad viewers. Over-preparation in particular was significantly enhanced in this group. After
application of the dental loupes to all students, no difference could be detected between bad and good viewers with respect to operative accuracy. As to preparation
depth and preparation angles, the differences that were detected between good and bad viewers or between first and second run showed clear tendencies towards
better preparation with better vision, but failed statistical significance.
Conclusion: Dental loupes can be recommended to all dental students and particularly benefit students with a bad natural vision. However, accuracy of more
complex cavity preparation tasks seem to be dependent on more skills and on individual training than on vision alone.
0132 (152294)
Screening of Oral Cancer by Using Mass Spectrometry Method
I. SZNT
1
, G. GELENCSR
2
, B. SNDOR
1
, and F. GALLYAS
3
ec||o o| Co| /eJ|c|e. |||co| Co| ||,|o|o,. Co| |o||o|o, oJ ^o|o,. |e| o| CJo|o|o,. ||.e||, o| oe|oe. oe|oe. |eo|.
2
|e| o|
|eoo|o|o,. oe|oe ||.e||, |o||o| . |||o||o|e|. oe|oe. |eo|.
3
|eo|e| o| |eoo|o|o,. |o||o| o| |e||c. |e||c. |eo|.
4
|eo|e|
o| C|||o|o|o,. O|o|o |o||o|. O|o|o. |eo|.
5
|e| o| CJo|o|o,. ec||o o| Co| /eJ|c|e e|c. ||.e||, o| oe|oe. oe|oe. |eo|
Objectives: To investigate the efficacy of the anti-CD20 antibody rituximab on the immune-mediated inflammatory changes in labial salivary gland tissue and on the
salivary gland function in patients with primary Sjgren's syndrome.
Methods: In this open-label study including 20 female patients (mean age 48 15 years) with primary Sjgren's syndrome fulfilling the revised American-European
Consensus Group Criteria, unstimulated and chewing-stimulated whole saliva and stimulated parotid saliva flow rates were measured and labial salivary gland
biopsies obtained before and 195 days after treatment with rituximab (infusion of 1,000 mg on days 1 and 15). The biopsies were routinely processed, embedded in
paraffin wax and stained with haematoxylin/eosin. B- and T-lymphocyte distribution was analysed using immunohistochemistry. Also the relative amount of salivary
gland parenchyma and lymphocytic inflammation was assessed.
Results: At baseline, labial salivary gland biopsies revealed focal periductal lymphocytic infiltrates in all patients (mean focus score 3.7; range 1-12). After treatment,
the extent and amount of lymphocytic infiltrates, including germinal centers, decreased in 60% of the patients (focus score: 1.9; 0-12, p=0.02) Also the relative amount
of acinar and fat tissue increased and the relative number of B-cells and plasma cells decreased after treatment. Unstimulated and chewing-stimulated whole and
parotid saliva flow rates increased in 65%, 60% and 70% of the patients, respectively (mean increase from baseline: 39%, 21% and 18% (p=0.03, p=0.001 and p=0.02,
respectively). The improvement of salivary gland function did not correlate to the reduction in focal lymphocytic infiltration nor to age or duration of disease.
Conclusion: Our results indicate that B-cell depletion with rituximab can attenuate the immune-mediated inflammatory changes in labial salivary gland and
independently hereof improve salivary gland function in terms of whole and parotid saliva flow rates in the majority of patients with primary Sjgren's syndrome, and
presumably postpone the progression of the disease.
39
0139 (151913)
Salivary Albumin Concentration in Patients with Long-termPeriodontal Disease
J. MEURMAN
1
, K. KARI
1
, A. SAARINEN
1
, B. SDER
2
, P.-. SDER
2
, and M. YAKOB
3
|oco||, o| |eo||| oJ |||e c|ece. ||.e||, o| ||e /e| o| e|oJ. |||o|. |||eJ ||Jo.
2
|oco||, o| |eo||| oJ |||e c|ece. ||.e||, o| ||e /e| o| ||oJ. |||o|.
|||eJ ||Jo
Objectives: A modified flat-bed perfusion biofilm matrix system was tested using active toothpaste formulations directly without dilution, as a layer in direct contact
with the biofilm matrix surface. Final biofilm yields and VSC biogenesis were measured to show the relative efficacy of toothpaste formulations.
Methods: Diffusion characteristics of the flat-bed system to active treatment with meridol HALITOSIS tooth & tongue gel (TTG; 1400 ppm F- from amine
fluoride/stannous fluoride, 0.5% zinc lactate, oral malodour counteractives) was assessed using a bioluminescent target species coupled with a low light photon
camera to visualise the kill kinetics. Three biofilms received 5, 15 and 30-min treatment with TTG respectively to determine the optimum time of exposure. VSC
biogenesis was measured from headspace by OralChroma prior to and following treatment of 2 daily applications for 4-days of treatment and controls (placebo, 1%
chlorhexidine gel and sham treatment). Viable counts were performed at the end of experiments by destructive sampling and plating on selective and non-selective
agar.
Results: Following treatment with TTG, the biofilm with lux target gave >50% reduction before recovering to a steady-state over 10 h suggesting that the treatment
mechanism was bacteriostatic inhibition. For 15 and 30-min treatment exposure, almost identical reductions in final biofilm yields were seen. Biofilms treated with
TTG gave greatest reductions in both pre-post levels of H2S (P<0.01) and CH3SH (P<0.05) and population yields at the end of the experiments (p<0.001).
Conclusion: The in vitro flat-bed perfusion model may be used to replicate many of the activities and reactions believed to be occurring by the tongue biofilm
microflora within a real mouth, including VSC biogenesis and their inhibition by exposure to active agents as components of toothpastes and gels applied in direct
contact with the biofilm. Supported by GABA International AG.
0145 (151867)
Comparison of Reverse Headgear and Chincap in Class III Malocclusions
Z. SARI
1
, M. AKIN
1
, C. CHOUSEIN
1
, G. BISIRICI
2
, and M.E. UYGUN
2
4
integrin.
The expression of different stem cell markers: CD44H, Nestin, Nanog, Oct3/4, CD117 was checked by immunofluorescence. The ability of
6
4
pos
CD71
neg
fraction to
form oral epithelial equivalents was also assayed.
Results: Three different oral keratinocyte subpopulations were obtained following magnetic separation:
6
4
pos
CD71
neg
,
6
4
pos
CD71
pos
and
6
4
neg
. Our
6
4
pos
CD71
neg
stem cell fraction was positive for Oct , CD44H and cytokeratin 19 while Nanog, Nestin and CD117 expression was absent. At the same time the other two
cell fractions
6
4
pos
CD71
pos
and
6
4
neg were negative for all stem cell markers. Also
6
4
pos
CD71
neg
fraction was able to regenerate a well stratified and organized
41
oral epithelial equivalent. The distribution of cytokeratin 19 and involucrin in the oral epithelial equivalent reflected the in-vivo situation in oral gingival epithelium.
Conclusions: The human gingival
6
4
pos
CD71
neg
fraction was strongly positive for a panel of stem cell markers and could form oral epithelial equivalent. It is also
suggested that a magnetic system may be an important tool in acquiring oral keratinocyte stem cells for research.
0147 (152139)
Condylar Asymmetry InTrue Unilateral Posterior Crossbite Patients
Z. ILERI, F.A. BASCIFTCI, and M. GUZES
|oco||, o| |e|||,. e|co| ||.e||e|. |o,o. o|e,
Objectives: Unilateral posterior crossbite involves multiple teeth on one side of arch and can be defined either as functional crossbite or true (skeletal) unilateral
posterior crossbite. In true unilateral posterior crossbite, the posterior teeth on one side of maxilla are positioned more palatinally than the posterior teeth on that side
of mandible. It was reported that in skeletal unilateral posterior crossbite, because of compensation of lateral shift of the mandible, condylar heights in crossbite side
are shorter than in noncrossbite side. The purpose of this study was to investigate condylar and ramal asymmetries in true unilateral crossbite patients as compared
with normocclusive subjects.
Methods: The study group consisted of 21 patients (14 girls and 7 boys) with the mean age 14.31 2.68 years and the control group consisted of 21 patients (13 girls
and 8 boys) with the mean age 13.08 0.84 years. Condylar (CH), ramal (RH), and condylar-plus-ramal (CH + RH) asymmetry values were computed for all subjects on
panoramic radiographs. The asymmetry indexes of the CH, RH and CH + RH were also computed by using a predefined formula. Data were analyzed statistically with
ANOVA for repeated measures and univariate ANOVA.
Results: In both groups no difference was found between the sexes. In the study group, on crossbite side, RH and CH + RH were smaller and CH was longer than
those of the non-crossbite side but all measurements were not statistically significant in both groups. CH, RH and CH + RH asymmetry indexes were higher in the
crossbite group than in the control group, and statistically significances were seen in the condylar and ramal index (p<0,01). Group-sex interaction was significant in
condylar index.
Conclusion: The patients with true unilateral posterior crossbite had more asymmetric condyles when compared to normocclusive subjects.
0148 (152188)
Craniofacial Changes After Facemask With Rapid Maxillary ExpansionVersus Facemask
H.S. ECE, Z.M. BAKA, Z. ILERI, and C. CHOUSEIN
|oco||, o| |e|||,. e|co| ||.e||e|. |o,o. o|e,
Objectives: The aim of this study is to evaluate posttreatment skeletal changes after face mask therapy (FM) and face mask therapy combined with rapid maxillary
therapy (FM+RME) in subjects with Class III skeletal malocclusions.
Methods: There were two groups (26 patients) in this study. The first group (FM+RME) consisted of 13 patients (mean age of 11.6 years, 9 female and 4 male) were
treated by a Delaire type face mask with bonded acrylic-splint rapid maxillary expander and the second group (FM) consisted of 13 patients (mean age of 10.4 years, 9
female and 4 male) were treated by Delaire type face mask with a bonded acrylic-splint. It was applied a protraction force of 400 to 600 gf to both groups. Once
adequate overjet (min 2 mm) was obtained in both application groups, face mask therapy was ended. Cephalometric radiographs were taken at the beginning (T1)
and end of treatment (T2). The mean treatment times were 6.8 months and 5.9 months for FM+RME and FM, respectively. The skeletal changes were evaluated on
cephalograms. Data were analyzed statistically with paired-t test and ANOVA.
Results: A significant increase in the sagittal growth of the maxilla (SNA angle, A-VR and A-MaxVR length), ANB angle, total, upper and lower anterior face height,
midfacial lenght, incisor overjet were seen in both groups. Statistical significance was seen only in the FMA angle in the comparison of two groups (p<0.01). Vertical
dimensions of FM+RME group increased more than FM group.
Conclusions: Both appliances are effective in the treatment of Class III malocclusions. However in the patients who have critical bite the clinicians should be careful in
using face mask therapy with rapid maxillary expansion because of decreasing in overbite and increasing in vertical dimensions.
*This project is supported by Selcuk University Scientific Research Project.
0149 (152221)
Soft-Tissue Changes After Facemask With Rapid Maxillary ExpansionVersus Facemask
Z.M. BAKA, H.S. ECE, Z. ILERI, and C. CHOUSEIN
|oco||, o| |e|||,. e|co| ||.e||e|. |o,o. o|e,
Objectives: The aim of this study is to evaluate posttreatment soft tissue changes after face mask therapy and face mask therapy combined with rapid maxillary
therapy in subjects with a Class III skeletal malocclusion.
Methods: The sample (26-patients) divided into two groups. The first group (FM+RME) consisted of 13 patients (mean age of 11.6 years, 9-female and 4-male) were
treated by a Delaire type face mask with bonded acrylic-splint rapid maxillary expander and the second group (FM) consisted of 13 patients (mean age of 10.4 years,
9-female and 4-male) were treated by Delaire type face mask with a bonded acrylic-splint. A protraction force of 400 to 600 gf was applied to both groups. Once
adequate overjet (min 2mm) was obtained in both application groups, face mask therapy was ended. Cephalograms were available at 2 time periods: pretreatment
(T1), end of active treatment (T2). The mean T1-T2 interval was 6.8 months for FM+RME and 5.9 months for FM. The soft tissue changes were evaluated on
cephalograms. Data were analyzed statistically with paired-t test and ANOVA.
Results: A significant increase in H angle, facial contour angle, lower face height(Sn-Me'), anterior displacement of upper lip, posterior displacement soft tissue
pogonion and decrease in lower vermillion height(Sti-Li) were seen in both groups. In the comparison of two groups, soft tissue pogonion, pogonion and lower lip
displaced more posteriorly (p<0.01) and upper lip height increased much more and upper incisor view decreased much more in FM+RME group (p<0.05). Nasolabial
angle increased in FM+RME whereas it decreased in FM group.
Conclusion: In Class III patients, both appliances are effective in correction of profile. In severe Class III patients, who grows horizontally, soft tissue profile can be
improved with using rapid maxillary expansion and face mask together.
*This project is supported by Selcuk-University-Scientific-Research-Project.
0150 (152026)
Effects Of Hydrogen Peroxide On Human Enamel Structure
T. BISTEY
1
, I.P. NAGY
2
, A. JENEI
3
, and C. HEGEDS
1
|eo|e| o| |o||e||c |e|||,. ||.e||, o| |eece /eJ|co| oJ |eo||| c|ece e|e. |eece. |oo,.
2
|eo|e| o| ||oc|e||, oJ /o|eco|o ||o|o,.
||.e||, o| |eece. /eJ|co| oJ |eo||| c|ece e|e. |eece. |oo,.
3
|eo|e| o| ^o|o, |||o|o, oJ |,o|o,. ||.e||, o| |eece. /eJ|co| oJ
|eo||| c|ece e|e. |eece. |oo,.
4
|eo|e| o| |o||e||c |e|||,. ||.e||, o| |eece /eJ|co| oJ |eo||| c|ece e|e. |eece. |oo,.
5
/eJ|co|
|eo||| c|ece e|e. ||.e||, o| |eece. |eece. |oo,
Objectives: Tissue Transglutaminase (TG) has effect on numerous physiological and/or pathological functions. The role of extracellular TG2 has been demonstrated
previously in cell adhesion, extracellular matrix assembly or bone ossification, however in vivo / in vitro studies have not been carried out yet to assess the effect of
TG2 on tooth development. Samples taken fromTG2 null mice were studied to characterize its tooth phenotype.
Methods: Mice were sacrificed at different developmental stages as follows: intraembryonic developmental stages (E 14, 15, 16), prior to tooth eruption (postnatal
day 1), and adulthood (2 months postnatal). Microscopical and computer aided 3D morphological measurements and enamel hardness test were carried out.
Results: We could not detect any obvious morphologic alterations due to the loss of TG2 during early tooth development phases, when the tooth germs were going
through bud, cap and bell morphogenetic stages. Significant differences in the hardness of the enamel were measured at postnatal stage, which implies accelerated
enamel mineralisation. It has been revealed by 3D analysis of incisors from the knockout mice that they were slightly longer with a thicker enamel layer than their
wild-type controls.
Conclusions: Our findings suggest that TG2 may have an effect on enamel bio-mineralization processes. The work/publication is supported by the TMOP 4.2.1/B-
09/1/KONV-2010-0007 project. The project is co-financed by the European Union and the European Social Fund.
0153 (152307)
Evaluation of AmF on Dentine Tubule Occlusion In-vitro Study
T. BACHANEK
1
, R. CHALAS
1
, J. NOWAK
2
, and A. KUCZUMOW
2
|eo|e| o| |e|o| |ooeJeo||c. |o||o |o||eoo ||.e||, o| /eJ|c|e oJ ||ooc,. |o,|ooco. |oo|o.
2
|eo|e| o| /eJ|co| ||oo||c oJ ||o|o||||c.
|o||o |o||eoo ||.e||, o| /eJ|c|e oJ ||ooc,. |o,|ooco. |oo|o.
3
|o||o /o|Jo.o ||||o|e o| |o||c |eo|||. |o,|ooco. |oo|o
Objectives: 1. to assess the frequency of addressing the dental office for emergencies versus routine check-ups or other dental treatments 2. to determine the self
perception of oral health status in a sample of adult patients from North-Western Romania.
Methods: A descriptive cross-sectional study was conducted on a sample of 1340 subjects, using a self-administered questionnaire. Information on the most frequent
reasons for addressing the dental office, as well as on the subjects' self perceived oral health status was obtained. The sample was stratified by age, gender and
educational background and data were processed using descriptive statistics.
Results: The study showed that 27% of patients addressed the dental office for emergencies (tooth ache) and 52% for routine check-ups. A considerable proportion
of patients (15%) sought aesthetic treatments while a lower number sought assistance for other affected oral functions. The highest demand for routine check-ups
was noted in the 21-35 age group (61%) and the lowest in the >55 age group (28.6%). Demand for emergency interventions was highest for the <21 age group
(29.4%) and lowest for the 36-55 age group (18.8%), while aesthetic treatments were mostly requested in the 36-55 age group (25%). Patients perceived their oral
health status as good (33%), acceptable (52%), weak (11%), and very weak (3%), while 1% declared not being able to appreciate it. Self perceived oral health worsened
with age.
Conclusions: 1. The most frequent reason for addressing the dental office was the routine check-up, followed by emergencies and aesthetic considerations. 2. The
distribution of motivation varied according to age and educational background, being less influenced by the subjects' gender 3. The self perceived oral health status
became less favorable with age.
48
0173 (151706)
Prevalence of TMDs, their relationships with orthodontic anomalies in Hungary
P. HERMANN
1
, P. FEJRDY
1
, M. KAN
2
, J. BORBLY
1
, L. GTAI
1
, and M. MADLNA
2
|oco||, o| |e|o| /eJ|c|e. v|c|o |oe ||.e||, o| /eJ|c|e oJ ||ooc,. ||ooo. |oo|o.
2
|o|oco ||o ||||o|e o| |eeoc| | |e||,. |oe|o|,o| ||.e||,.
|o,|ooco. |oo|o.
3
|eo|e| o| Ceo||.e |e|||, oJ |JoJo||c. ||.e||, o| eeJ |oco||, o| |e|||,. eeJ. |oo,.
4
|eo|e| o| Co| oe,.
||.e||, o| eeJ |oco||, o| |e|||,. eeJ. |oo,
Objective: The aim of this study was to evaluate the push-out bond strength of two self-adhesive resin cements used for the cementation of glass fiber posts.
Materials and Methods: Sixty recently extracted non-carious human molars, with one straight palatal or distal root canal and fully developed apices extracted for
periodontal or orthodontic reason were selected for this study. After endodontic treatment, glass fiber posts (RelyX Fiber Post, Size 3, 3M ESPE) were cemented with
two types of self-adhesive resin cements (RelyX U200, 3M ESPE, and Maxcem Elite, Kerr). Perpendicular to the post, four to six sections of 1 mm height were cut from
each specimen using a diamond saw (Isomet 1000, Buehler) starting 1 mm coronal from the tip of the post. Each section was tested on push out bond strenght with
the testing machine (0.5 mm/min, Lloyd Instruments Ltd, Fareham Hants, UK). The retentive strength of the post fragment (MPa) was calculated by dividing the load
at failure (N) by the interfacial area of the post segment. Failure modes were evaluated by a single operator under a stereomicroscope (Stemi 2000-C; ZEISS, Jena,
Germany) at 40x magnification and SEM.
Results: Push out bond strength of RelyX U200 (8.34.1) was higher than that of the Maxcem Elite (6.13.8). Failure mode was predominantly at resin cement/dentin
interface. The results recorded were statistically different when was evaluated with one-way analysis of variance and Tukey test (p<0.05).
Conclusions: Push out bond strength was influenced by cement type and varies upon different regions of the root canal. Adhesive interface between resin cement
and root dentin was the most fragile region.
Acknowledgements: The study was supported by 3M ESPE AG, Seefeld, POSDRU/88/1.5/S/63117 Grant and IDEI 1047 Grant.
0191 (153461)
Microleakage and Bond Strength of a NewSelf-Etch Adhesive
B. CZARNECKA
||oo|e|o| |e|e|o| |e|||,. |oo ||.e||, o| /eJ|co| c|ece. |oo. |o|oJ
Aim: To evaluate adhesion of new composite bonding system Uno (3M ESPE) to dentine and enamel.
Material and methods: 20 sound human molar teeth, extracted for orthodontic reasons, were used. All teeth were prepared in the same way; two class II cavities
were prepared, of the depth of medium caries. The teeth were randomly divided into 4 groups; Group A filled with composite Filtek and Uno bonding system LC with
etching, Group B: composite Filtek and Uno LC without etching, Group C: composite Filtek and Uno SC with etching, Group D (control): Herculite with Optibond FL.
All procedures were carried out according to manufacturers recommendation. After filling, all teeth were stored for 24h in high humidity at 37C then sectioned
longitudinally using a low speed diamond saw. The sections were polished and evaluated microscopically with particular attention to the material-enamel, material-
dentine interfaces at the bottom of cavity and adjacent to the storage environment. Shear bond strengths were also determined, using bovine dentine and enamel,
results were subjected to statistical analysis.
Results: All groups showed complete seals with both enamel and dentine, with no observable differences between them. In all case, the seal appeared complete along
the entire length, with no interfacial gaps or other evidence of debonding. This applied equally to enamel and dentine in both experimental and control groups.
Conclusions: Both etched and non-etched groups showed excellent seals, suggesting that prior etching is not essential for establishing such seals with this material.
Use of the Uno bonding system as either SC or LC was equally effective at providing seals with enamel and dentine. Shear bond strengths for this system will also be
discussed.
0192 (153462)
In-vitro Results with a NewSelf-Adhesive Resin Cement
G. STERZENBACH
|e| o| |o||oJo||c. Oe|o||c |e|||, oJ o|ooJ|o|o ||oJe. |o||e ||.e||, o| /eJ|c|e. |e||. Oeo,
Recently, the appropriate, durable bond of adhesive systems and composite resin cements to retain endodontic posts was challenged. The question arises whether it
wouldbe possible to adhesively lute fiber posts in a less technique sensitive approach using a self-adhesive composite resin cement (SARC). The influence of bonding
techniques on the push-out bond strength and load capability of post-endodontic restorations were investigated comparing etch-and-rinse and self-etch adhesives
with SARC.
0193 (152070)
Effect of curing on clinical retention. A 7-year evaluation
J.W.V. VAN DIJKEN
|e| o| CJo|o|o,. |eo ||.e||,. |e. .eJe. oJ | |^|||||. oJ|oee|o|e. |oe|o. ||.e||,|. |oe|o. |. |eo|
Objective: To evaluate in a prospective evaluation the retention of Class V compomer and hybrid resin composite restorations placed with a 1-step self etch system
and cured with continuous, soft-start and pulse-delay curing.
53
Methods: 139 Class V restorations were placed and cured at random in 60 subjects with a compomer (Dyract AP;68) or resin composite (Tetric Ceram:67) and cured
for 40s with continuous, soft-start and pulse-delay modes. The restorations were evaluated with slightly modified USPHS criteria yearly during 7 years.
Results: Of 135 restorations evaluated at 7 years, 29 were lost, 17 compomer (25%) and 12 Tetric Ceram (18%). The cumulative loss rates for the compomer and resin
composite restorations cured with the three curing modes were. continuous cure: 26.1%/18.2%, soft-start: 22.7%/19.0%, pulse delay: 26.1%/16.7%. No statistical
difference were seen between the curing modes.
Conclusions: The clinical retention of Class V compomer and resin composite erosion/abrasion restorations was notinfluenced by the curing modes used.
0194 (151626)
Clinical Evaluation Of A Low-shrinkage Composite After 1Year
B. BARACCO
1
, J. PERDIGAO
2
, E. CABRERA
1
, I. GIRLDEZ
1
, and L. CEBALLOS
1
||o|o|co| c|ece. ||.e||e Je |,o. ||.e||e |,o . |oco||e JCJo|o|o|e. |o|ce |.|| Je |,o. e.|ce JCJo|o|o|e. |,o. |oce.
2
||o|o|co| c|ece. ||.e||e Je
|,o. ||.e||e |,o . |oco||e JCJo|o|o|e. |,o. |oce.
3
|e.e|oee|. |ec|ec|e e| |o.o||o. |ooo|o|e |oc|ece. |eo. |oce.
4
|co|e |oo|e oe|eoe
Je |,o. |,o. |oce
Previous studies have suggested that human odontoblasts are involved in the dental pulp immune and inflammatory response to oral pathogens that invade dentin
during the caries process. However, how odontoblasts regulate the early pulp response to Gram-positive bacteria, which predominate in shallow and moderate
dentin caries, is not completely understood. We previously showed that activation of Toll-like receptor (TLR)2, a pattern recognition molecule activated by lipoteichoic
acid (LTA) from Gram-positive bacteria, triggers TLR2 up-regulation, NF-B nuclear translocation, and production of pro-inflammatory chemokines and cytokines,
including CXCL8 and IL-6, by odontoblasts in vitro.
Objective: To determine whether odontoblast activation by LTA is modulated by the lipopolysaccharide-binding protein (LBP), an acute-phase protein over-
expressed in inflamed pulps which has been shown to interact with LTA.
Methods: Human teeth were collected with the informed consent of the patients, in accordance with the Declaration of Helsinki and following a protocol approved
by the local ethics committee. Odontoblast-like cells were differentiated from pulp explant cultures derived from non-erupted healthy third molars. Cells were
stimulated for 4 h with various concentrations of LTA, alone or in association with LBP. Gene expression of the pro-inflammatory chemokine CXCL8, the cytokine
interleukin-6 (IL-6), and the LTA receptor TLR2 was assessed using real-time PCR. Results were expressed as mean values SD and statistical analysis was determined
with Student's t test.
Results: CXCL8, IL-6 and TLR2 genes were significantly up-regulated by LTA, but this increase was reduced when LBP was added together with LTA in the culture
medium.
Conclusion: These data demonstrate that LBP negatively regulates TLR2 signalling induced by LTA in human odontoblasts and might play a role in protecting human
dental pulp from excessive immune response to cariogenic Gram-positive bacteria. Supported by University Lyon 1, CNRS, IFRO and Rgion Rhone-Alpes.
0200 (152181)
Human dental pulp stemcells differentiate towards peripheral glial cells
W. MARTENS, A. BRONCKAERS, T. STRUYS, C. POLITIS, I. LAMBRICHTS
||oeJ |oc||oo| /o|o|o,. ||.e||e|| |oe||. ||eeee|. |e||o
Objectives: In the peripheral nervous system, Schwann cells (SCs) are responsible for the formation and preservation of myelin sheaths around axons. Also, SCs play
an important role in the regeneration of peripheral nerves after Wallerian degeneration. However, for the treatment of peripheral nerve injury, an alternative cell
source is needed since SCs are difficult to obtain and the clinical applications are difficult. Recently, it has been described that dental pulp stem cells (DPSC) are
capable of differentiating into glial and neuronal cells and are able to produce neurotrophic factors like BDNF, GDNF and NGF. Since DPSC already express glial
markers like S100 and NGFRp75, it is interesting to further investigate their potential to differentiate into glial cells of the peripheral nervous system, like SCs.
Methods: DPSC were isolated from human dental pulp tissue and cultured via the explant method. When confluency was reached, cells were subcultured and media
was changed every 3-4 days. In vitro, DPSC were stimulated to differentiate into SC-like cells via a mix of growth factors. After 21 days in culture, the differentiation of
DPSC towards SCs was analyzed. Via immunocytochemistry, the expression of SC markers GFAP, S100 and NGFRp75 was evaluated. To further elucidate the
differentiation into SC-like cells, reverse-transcriptase PCR, cytokine array, and transmission electron microscopy was performed.
Results: At the mRNA level, transcripts of GFAP, p75 and S100 were observed in SC differentiated DPSC. These results were confirmed by immunocytochemical
analysis. Furthermore, an increased production of neurotrophic factors like BDNF, GDNF, NCAM-1, NT-3 and TGF-Beta1 was found. Ultrastructural analysis showed a
Schwann cell morphology.
Conclusions: The results of this study indicate that DPSC are capable of differentiating towards peripheral glial cells, like SCs. Therefore, DPSC could be an alternative
cell source for future stem cell treatment of peripheral nerve injuries.
55
0201 (152182)
Angiogenic properties of human dental pulp stemcells (hDPSC)
A. BRONCKAERS, W. MARTENS, P. HILKENS, C. POLITIS, and I. LAMBRICHTS
BIOMED- Functional Morphology, Universiteit Hasselt, Diepenbeek, Belgium
Objectives: Since the currently used prostheses are prone to biological and mechanical failure and inorganic pulp replacement materials often lead to pulp necrosis,
there is an urgent need for new pulp regeneration strategies. Recently, adult mesenchymal stem cells have been isolated from tooth dental pulp tissue. These human
dental pulp stem cells (hDPSC) have the capacity for multilineage differentiation into cell types such as chondrocytes, osteoblasts and neural-like cells and are
currently evaluated in clinical trials for bone tissue engineering. Moreover, this stem cell population has been suggested to provide an effective strategy for pulp
regeneration. As neovascularisation is a crucial event for the success of pulp tissue regeneration, we investigated into detail the angiogenic activities of hDPSC.
Methods: We evaluated the angiogenic proteins produced by the hDPSC by means of an antibody array. The results of this array were validated by ELISA and RT-PCR.
Furthermore the biological effects of the hDSPC on mouse brain endothelial cells (MBEC) were investigated with an in vitro proliferation and migration assay.
Results: Numerous angiogenic factors such as vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), monocyte chemotactic protein-1 (MCP-1), fibroblast
growth factor-2 (FGF-2) are highly expressed by these stem cells. Also anti-angiogenic factors such as endostatin and TIMP-1 were found in the conditioned medium
of the hDPSC. Moreover, hDPSC significantly induced MBEC migration in vitro, while no effect on MBEC proliferation could be found.
Conclusions: Our data clearly show that hDPSC are able to induce angiogenesis in vitro, particularly endothelial cell migration. In the future, the potential effect of
hDPSC on the endothelial survival and tube forming capacity will be investigated. If hDPSC are able to contribute to vascular networks, this will have great
therapeutic potential, not only in terms of pulp regeneration, but also as a cell-based therapy for stroke and myocardial infarctions.
0202 (152219)
Contribution of pulpal stemcells to heal a wounded pulp
S. DIMITROVA-NAKOV
1
, Y. HARICHANE
1
, A. HIRATA
2
, A. POLIARD
3
, M. GOLDBERG
1
, and O. KELLERMANN
1
||||/|/| .4.. ||| ||oeJ|co|e Je o|||ee. ||.e||e |o| |eco|e. |o|. |oce.
2
|eo|e| o| /o|e|o| oJ |||e c|ece. OoJoo|e c|oo| o| ||ee|.
Co|o ||.e||,. o||o. Co|o. .oo.
3
||.e||e |o| |eco|e. /o|ooe. |oce
Objectives: Our aim was to (1) localize cells entering in mitosis in response to pulp injury and (2) evaluate whether the implantation of pulpal multipotent progenitors
improves tooth repair in a rat molar after pulp exposure.
Methods: (1) Immunohistochemical analysis of the cell proliferation zones 24-48h after pulp exposure. (2) Histological analysis of dentin formation after implantation
of pulp-derived clonal precursor cells in the rat molar.
Results: We have identified three well-delimited zones of cell proliferation 24-48h after pulp exposure. In the crown, cells leaving their quiescent state are recruited in
the isthmus between the mesial and central parts of the pulp chamber as well as between the coronal pulp and the upper pulp part of the root. The restricted
location of these mitotic cells within the crown precisely overlaps the area where the dentinal bridge will be formed. In the root, far from the inflammatory site,
proliferative cells can also be visualized near the apex. Besides, by exploiting a mouse pulp-derived cell line, we provide the prime evidence that implantation of
exogenous stem cells in a rat molar leads to the formation of a robust dentin barrier. Osteodentin totally fills the mesial pulp chamber and in turn, protects the
residual pulp. The pulp vitality is preserved and the inflammatory process is also rapidly resolved. Thus, a pulp-derived stem cell line has the ability to contribute to
heal a wounded pulp when re-introduced within its natural environment. These data provide the foundation for characterizing the signals that support their
reparative activity.
Conclusions: Future prospects will aim to determine whether the implanted pulpal cells are directly involved in reparative dentin formation or whether they induce
the recruitment and differentiation of host progenitor cells. Our pre-clinical experimental approach paves the way to the development of cellular therapies for pulp
injury.
0203 (151890)
The influence of prostaglandin D2 on human mesenchymal stemcells
H.-G. KIRCHNER, C. ERN, R. HICKEL, and M. FOLWACZNY
|eo|e| o| |e|oo||.e |e|||, oJ |e|oJo|o|o,. |oJ.|/o||||o||.e||,. /o|c|. Oeo,
Objective: Periodontal regeneration starts with the proliferation and differentiation of progenitor cells and the formation of the extracellular matrix. Mesenchymal
stem cells (hMSCs) are able to differentiate into cells of the periodontal complex and form periodontal tissue. Previous studies indicate, that prostaglandin D2 (PGD2)
is a potent modulator of osteoblastic function and bone formation. The aim of this study was to observe the influence of PGD2 on proliferation and differentiation of
hMSCs.
Methods: hMSCs were cultivated with three different concentrations of PGD2 (0,1ng/ml; 0,5ng/ml; 1,0ng/ml). Cells were counted and the cumulative population
doubling was calculated at 1, 2, and 4 weeks. Additionally hMSCs were stimulated with osteogenic supplements and PGD2. Following the osteogenic stimulation, the
amount calcium deposition was determined and histologically assessed. The expression of osteogenic markers after 21 days was determined using RTQ-PCR.
Statistical analysis was perfomed, using Games-Howell test at a level of significance of p<0.05.
Results: Compared to the unstimulated control-group, the population-doubling of the 0,1ng/ml and the 1,0ng/ml PGD2 group decreased on day 21 and 28. The
population doubling of the 0,5ng/ml PGD2 group was similar to that of the control-group. The amount of deposited calcium decreased in all PGD2 stimulated groups
compared to the control group. The RNA-expression of alcaline phospatase (p<0,001) and collagen I (p<0,001) was significantly higher in the 0,5ng/ml concentration-
group compared to the other PGD2 groups and the control group.
Conclusion: The results indicate, that PGD2 has no effect on the proliferation rate but a strong effect on the regulation of osteogenic differentiation and bone
formation at a concentration of 0,5ng/ml. Higher and lower concentrations of PGD2 inhibited the proliferation and the osteogenic differentiation of hMSC. Based on
these observations it can be assumed, that the influence of PGD2 on hMSC follows a very fine regulated concentration-dependent system.
0204 (153465)
Introduction: Management of Dental Caries: HowRelevant Are Properties of Restorative Materials?
M.C. PETERS
c|oo| o| |e|||,. ||.e||, o| /|c||o. ^ ^o. /|
All around us, science is rapidly expanding with new knowledge. Focusing on health care, many dentists and dental researchers are involved in these developments.
Cutting-edge research continues to cross the boundaries of established domains, exploring new venues in search for answers to unresolved clinical problems.
Whether that new knowledge is in dental materials science, our profession's backbone for decades, or moves to incorporate biological and social sciences, our
knowledge base is expanding exponentially in each of these arenas.
How does this relate to the management of dental caries? Despite the many advances over the last decades, caries disease is still a major health care problem for
many of us, and increasingly so on a global scale. This presentation is placing biologic and materials advances in a broader perspective, to show their potential
complimentary impact on oral health: on dental practice, research and health care policy.
56
0205 (153466)
Properties of Dental Materials for the Next 20Years: a Delphi Survey
R. SEEMANN
1
, and M.J. NOACK
2
||.e||, o| |e. .||e|oJ. |e||,. |o|o. Oeo,.
2
c|oo| o| |e|||,. ||.e||, o| o|oe. |oe|. Oeo,
The aims of this study were to forecast trends in restorative dentistry for the next 20 years and to determine treatment goals and corresponding material properties.
Methods: A panel of 4 experts identified 8 key questions, which were sent to international experts in restorative and preventive dentistry using the DELPHI method.
The survey was administered as internet questionnaire by TNS EMNID (Germany). A first round with 15 international experts resulted in a semantic precision of the
questions and the completion of the items for two additional rounds. In the second round 105 experts from 35 countries rated the items developed in round 1 of the
8 questions by using a Likert scale. In round 3 the same experts received the results of round 2 and were asked to agree or disagree to the results by re-voting all
questions. Among the 8 questions the following 2 questions were of interest regarding this report: Q1) What will be the future role of restorative treatment?, and Q6)
What will be the key qualities for clinical success of restorations?. For both questions the experts were asked to evaluate the importance and the feasibility for each
item of the questionnaire. Results and Conclusions: As expected all items developed by the experts in round 1 were regarded to be important expressed by the fact
that the mean values for the future importance of items ranged between 2.8 and 3.8 (Likert scale 1-4). The most important items for Q1 werepreservation of existing
enamel and dentin tissue, prevention of secondary caries, maintenance of the pulp vitality andimprovement of aesthetics, and for Q6optimization of adhesion,
biocompatibility, andminimization of technical sensitivity. Prevention of secondary caries was rated as having a high potential (potential = (importance +
(Importance-Feasibility)) for future restorative treatment in general and key property of future dental materials. The survey and particularly the procedure support of
the internet based survey was sponsored by DENTSPLY DETREY, Germany
0206 (153467)
Dental Materials' Needs for the Management of Caries Risk Groups: a Delphi Survey
M.J. NOACK
1
, and R. SEEMANN
2
|eo.e ||C/^ |eeoc| |o|e. |eo|e| o| oe.o||.e |e|||,. o||o||c ||.e||, o| |eo.e. |eo.e. |e||o.
2
|eo|e| o| |e|oo||.e |e|||,. |o||o|Jo
||.e||,. ooo. .oo
Objectives: To determine the micro-tensile bond strength (TBS) of two self-etch adhesives to bur-cut and uncut enamel.
Methods: The buccal and lingual enamel surfaces of 15 teeth were ground flat using a 100-m diamond bur (bur-cut enamel), while the enamel surface of another
set of 15 teeth were solely prophylactically cleaned (uncut enamel). Resin composite (Herculite XRV Ultra, Kerr) was bonded to the surfaces using either the 2-step
self-etch adhesives OptiBond XTR (Kerr) or Clearfil SE Bond (Kuraray), or the 3-step etch-and-rinse adhesive OptiBond FL (Kerr) that served as gold-standard control.
After 1-week water-storage at 37C, specimens were serially cut into 1-mm2 stick-shaped micro-specimens, of which per tooth half of them were further subjected to
20,000 thermo-cycles (TC). The TBS was determined at a crosshead speed of 1.0 mm/min. Failure analysis was performed using stereo-microscopy and SEM. Data
were statistically analyzed by ANOVA and post hoc Tukey test.
Results: After 1-week water storage and upon aging by thermocycling, both self-etch adhesives bonded significantly (p<0.05) less effectively to enamel than the
etch-and-rinse OptiBond FL control (both to bur-cut and uncut enamel), except when OptiBond XTR was bonded to bur-cut enamel and a similarly high TBS was
measured (p>0.05). Aging by thermocycling did not decrease the TBS for any of the adhesives as well as enamel substrates (p>0.05).
Conclusions: The best bonding effectiveness to enamel is still achieved by etching with phosphoric acid following an etch-and-rinse approach, while specific self-
etch adhesives may bond equally well on the condition that enamel is beforehand roughened by bur.
0216 (151664)
Influence of CHX on Microtensile Bond Strength of Self-etching Adhesives
K. BEKES, S. SIEGMUND, H.-G. SCHALLER, and C.R. GERNHARDT
|eo|e| o| Ceo||.e |e|||, |e|oJo|o|o,. /o|||o||e||.e||, |o||e/|||ee. |o||e. Oeo,
Objective: The aim of the present study was to evaluate the influence of different concentrations of chlorhexidindigluconate (CHX) on microtensile bond strength
(mTBS) of two self-etching dentin adhesives (Futurabond NR, Bond Force) in vitro.
Methods: 150 extracted third molars were included in this study. All teeth were specially prepared allowing the simulation of dentin perfusion. The specimens were
randomly assigned to one of the ten groups of fifteen samples each: group F-C: Futurabond NR, control group (no CHX-application); F-0.2: immersion for five minutes
in 0.2% CHX prior to bonding with Futurabond, F-2: immersion for five minutes in 5% CHX prior to bonding, F-5: immersion for five minutes in 2% CHX prior to
bonding, groups B-C, B-0.2, B-2 and B-5 followed the same procedure with Bond Force as adhesive. MTBS was measured 15 minutes after application of the
composite (Tetric Ceram) using a Zwick testing machine.
Results: Following mTBS were evaluated (mean values and standard deviations in MPa):
Statistical analysis showed a significant influence of the used dentin adhesive and the pre-treatment with CHX in different concentrations (p< 0.001, ANOVA). The
application of 2% and 5% CHX before bonding procedure (F-2, F-5, B-2, B-5) resulted in a significant reduction of mTBS compared to the untreated control groups (F-
C, B-C) (p< 0.05, Tukey test). Between the controls and the 0.2% CHX-groups, no significant differences could be detected (p> 0.05, Tukey test). Pairwise comparison
between Futurabond and Bond Force showed no significant differences in all groups (p> 0.05, Tukey test).
Conclusions: Within the limitations of an in vitro investigation it can be concluded that CHX in higher concentrations affected the mTBS of both tested self-etching
adhesive systems.
F-C F-0.2 F-2 F-5 B-C B-0.2 B-2 B-5
Mean 23.9 18.4 17.3 16.3 23.0 19.6 13.9 10.8
+/- 7.7 4.4 5.2 5.7 7.5 5.6 6.5 3.0
Technique n % n % n % n %
Direct 5 25 13 65 2 10 0 0
Indirect 11 55 7 35 1 5 1 5
Microleakage Frequency
0 1 2 3
Restorative
59
0217 (151665)
Effect of Pro-ArginTechnology on Bond Strength After Artificial Aging
C.R. GERNHARDT, A. REINBOTH, K. BEKES, and H.-G. SCHALLER
|eo|e| o| Ceo||.e |e|||, |e|oJo|o|o,. /o|||o||e||.e||, |o||e/|||ee. |o||e. Oeo,
Objectives: The aim of this study was to evaluate the effect of a recently introduced desensitizing paste based on Pro-Argin technology (elmex Sensitive Professional
Desensitizing Paste, GABA, Germany) on microtensile bond strength of a total etch adhesive system (Syntac, Vivadent, Liechtenstein) after artificial aging using water
storage and application of a provisional cement (Temp Bond, Kerr, Germany).
Methods: 60 freshly extracted third molars were included. All teeth were specially prepared allowing the simulation of dentin perfusion and standardized conditions.
The specimens were randomly assigned to four experimental groups of fifteen each: group 1: control without desensitizer; group 2: desensitizing paste application;
group 3: desensitizing paste, water storage; group 4: desensitizing paste, application of Temp Bond, water storage. Group 3 and 4 were stored in water for one week.
In group 3 Temp Bond was additionally applied after desensitizer application. Microtensile bond strength was measured using a Zwick testing machine.
Results: For the test series following tensile bond strengths were evaluated (mean values and standard deviations in MPa): Group 1: 24.66 (+/-7.96), group 2: 15.54 (+/-
2.99), group 3: 13.61 (+/- 2.25), group 4: 16.16 (+/- 1.55). Statistical analysis showed a significant influence of the different aging procedures on microtensile bond
strength (p< 0.001, ANOVA). After application of the desensitizing paste a significant reduction of bond strength could be observed compared with the untreated
control (p< 0.05, Tukey test). Pairwise comparison showed no further significant reduction of bond strength in specimen after water storage and application of the
provisional cement (p> 0.05, Tukey test).
Conclusions: Within the limitations of an in vitro investigation it can be concluded that application of the desensitizing paste based on Pro-Argin technology might
affect microtensile bond strength of the used total etch adhesive system.
0218 (151951)
Influence of Surface Preparation on Performance of Self-Etch Adhesives
R.L. ZERGUINE
1
, H. LOLL
2
, R. GUGGENBERGER
3
, and C. THALACKER
2
||.||o o| |e|oo||.e |e|||,. |eo|e| o| Co| /eJ|c|e. |ooo.o |e|o| o||ee. `o|oo|o. .oo.
2
o|o|o||o o|o| e.|ce. oo||oo. .oo
Objective: If the tooth surface is covered with a colorless transparent silica thin film, it can be expected to prevent caries. Previously we have reported that the rapid
silica thin film coating method on enamel surface*. The purpose of this study was to examine the effectiveness of the silica coating method on acid resistance of
enamel.
Methods: 10% of preceramic polymer perhydropolysilazane (PHPS; AZ Electronic Materials, Tokyo, Japan) solution was used. Finely finished bovine enamel slabs (7 x 7
mm) were divided into two groups; silica thin film coated group and non-treated control group (n=5). PHPS was applied on the enamel surface and 40l of 3 %
hydrogen peroxide solution was dropped onto the PHPS-coated surface. PHPS was converted to silica by CO
2
laser (Opelaser-03S, Yoshida, Tokyo, Japan) irradiation for
1 min. All specimens were covered with nail varnish except for a window of 3mm diameter and immersed in 0.1 mol/l hydrochloric acid solution for 30 minutes. The
measurement of dissolved calcium ion concentration from the enamel surface was determined quantity spectrophotometrically by a colorimetric assay based on the
Arsenazo III reaction at a wavelength of 660nm. The data were analyzed statistically by One-way ANOVA and Tukey's test at p<0.01.
Results: After the acid resistance test, the mean calcium concentrations that dissolved into the hydrochloric acid of the silica film coated and control group were 0.03
mmol/l and 1.89 mmol/l respectively. The silica film coated group was showed significantly lower concentration of calcium compared with the control group.
Conclusion: It was suggested that the silica thin film coating method is promising to create a firm acid resistant layer on tooth enamel surface. * Tanaka T et. al., abst #
271, IADR-CED with NOF & ID congress in Munich, 9-12 Sept. 2009
0449 (152264)
Compomer vs. composite resin in caries-prone population: 2-year clinical evaluation
J. SINIAWSKA
1
, K. JURCZYK
1
, E. CIKA
1
, A. KOCZOROWSKA
1
, A. CZAJKA-JAKUBOWSKA
1
, J. STOPA
1
, and M.C. PETERS
2
|oco||, o| |e|||,. ||.e||, o| |eece /eJ|co| oJ |eo||| c|ece e|e. |eece. |oo,.
2
|eo|e| o| ||eo| /eJ|c|e |||c. ||.e||, o| |eece /eJ|co|
oJ |eo||| c|ece e|e. |eece. |oo,.
3
|eo|e| o| |||co| ||oc|e||, oJ /o|eco|o |o||o|o,. ||.e||, o| |eece /eJ|co| oJ |eo||| c|ece e|e.
|eece. |oo,
Objectives: The aim of this study was to investigate the associations between the oral health indicators and serum inflammatory and lipid parameters and human
paraoxonase-1 (PON1) activity in hyperlipidemic patients.
Methods: Thirty four Caucasian patients (mean age 55.1211.55) with hyperlipidemia and thirty four age- and gender matched healthy controls were enrolled. Dental
examination ( dental, periodontal status) and therapy (oral health care, endodontic, surgical treatment) was performed. We have investigated the serum levels of lipid
parameters ( triglicerids, cholesterol and liporpoteins), systemic inflammatory alpha) and the PON1 activity before,TNF,factors (CRP, IL-6, IL-1beta one week and 3
month after the complex dental therapy.
Results: After the 3 month follow up, there were significant improvements in the clinical periodontal characteristics including plaque index (PI) (p<0.01) and gingival
index (GI) (p<0.05). The PON1 activity was significantly increased after three months compared to the baseline (p<0.01). There was a significant reduction in the CRP
(p<0.01). There were significant differences in the microbial analysis of supragingival and subgingival plaque examination between the baseline and 3 months of
124
follow up in reducing the pathogenic flora (p<0.01). There were no significant reductions in the serum levels of lipid levels. There were significant parameters, IL-6 and
TNF-alpha differences between the control group and the patient group in the lipid parameters and the IL-1beta levels at baseline and at the follow up as well
(p<0.05).
Conclusions: To our knowledge, this is the first study, which investigates the effect of a complex dental therapy on PON1 activity and systemic inflammatory factors in
hyperlipidemic patients. The work/publication is supported by the TMOP 4.2.1/B-09/1/KONV-2010-0007 project. The project is co-financed by the European Union
and the European Social Fund.
0456 (151436)
Caries prevalence in Hungarian police students
I. FARAG
1
, S. MRTON
2
, F. TRY
3
, G. NAGY
4
, M. HOPCRAFT
5
, and M. MADLNA
6
|eo|e| o| Ceo||.e |e|||, oJ |JoJo||c. ||.e||, o| eeJ |oco||, o| |e|||,. eeJ. |oo,.
2
||eo| /eJ|c|e |eo|e|. ||ec|o|o, ||||o|e.
||.e||, o| eeJ. eeJ. |oo,
Objectives: Evidence of occupational exposure from dental unit water lines (DUWL) was first described in the 1960s. Since then it is known that dental unit water
lines hosts diverse microflora and are a source of occupational and healthcare acquired infection in dental settings. The aim of this study was to investigate the quality
and quantity of bacterial counts contained in the water, which is sprayed into the patient's mouth as a coolant for the high-speed drills and as an irrigant during
dental procedures.
Method: DUWL samples were collected according to thewater quality sampling for microbiological analysis standard from the dental units of the prosthetic
department and from the wash basins at the same department. The samples were examined at the Water Hygiene Department in the National Institute of
Environmental Health.
Results: The total bacterial counts in the water samples taken from the dental unit water lines was not only higher than in the samples taken from taps, but also
higher than the recommended limits of the water hygiene guidelines.
Conclusion: The findings of this study show that the quality of the water comming out of the dental unit water lines can be an important point in everyday routine
dental infection control. This study draws the attention on the importance of examining and controlling the quality of the water from the dental unit.This is especially
important when treating generally ill or immunocompromised patients at dental environments.
0472 (152156)
Yeast other than Candida albicans as oral colonizers
I. CAVALEIRO
1
, L. PROENA
2
, S. FLIX
1
, and M. OOM
1
e|o Je |.e||ooo ||eJ|c|||o |o /o|. |||/. ||||o|o oe|o Je |ec|o Jo ooJe |o /o|. oo|co. |o|oo|.
2
|||/. ||||o|o oe|o Je |ec|o Jo
ooJe |o /o|. ^|oJo. |o|oo|
Objectives: During the last decade, the isolation yeast species other than Candida albicans, have been increasingly detected in the oral mucosa, thus emerging as
important oral colonizers. We studied the distribution of the different yeast species carried in oral cavity and evaluated its association with dental prosthesis wearers-
related factors.
Methods: tRNA-PCR fingerprinting and sequencing of the 26S rDNA D1/D2 domain were used to identify the yeasts isolated from CHROMagar candida cultures of
oral swabs collected from 178 patients. Associations with the host-related factors were conducted by logistic regression analysis.
Results: The most frequently isolated species were C. albicans, C. glabrata, C. parapsilosis and C. tropicalis. However, 12 other species were identified corresponding to
17% of the yeast isolates. The majority of the non-C.albicans was not detected as single colonizers but in co-colonization with one or two other different yeasts, in
special with C. albicans (19% of the colonized subjects). The colonization with non-C.albicans and co-colonization were not independently associated with none of
the analysed host-related factors, in particularly, they were not significant risks factors for the elderly (age 65 years) or dental prosthesis wearers. Although
statistically not significant, acrylic based prosthesis wearers showed a higher frequency of non-C.albicans (23%) than their metal counterparts (10%). The best fitted
model indicates that the use of a dental prosthesis is effectively a risk for colonization by yeast in general (odds=3.84, IC95[1.6-9.3], p=0.003), but is not a risk for
colonization by non-C.albicans species, in particular.
Conclusion: The results of this study do not support the existence of a significant risk for dental prosthesis wearers to be colonized by non-C.albicans species.
Additionally, it was also shown that elderly, by itself, is not a risk factor to be colonized by those yeast species.
0473 (152207)
Treatment of oral halitosis: chlorhexidine mouthrinses
J. ZAMBON
1
, and V.I. HARASZTHY
2
|e|oJo||c oJ |JoJo||c |eo|e|. |o|e ||.e||, o| |e.`o| ||` |o||o|o. |o||o|o. |`.
2
|e|oo||.e |eo|e|. |o|e ||.e||, o| |e.`o| ||` |o||o|o.
|o||o|o. |`
Objective: Oral halitosis is commonly associated with volatile sulfur compound (VSC) - producing oral bacteria mainly on the dorsal surface of the tongue. This study
examined the effect of a chlorhexidine mouthrinse on oral halitosis and on VSC - producing oral bacteria.
Methods: Oral halitosis was assessed as VSC's >180 ppb and organoleptic scores >3 in 52 subjects between 23 - 79 years including 14 periodontally normal subjects,
21 subjects with plaque-associated gingivitis and 17 subjects with oral halitosis. Subjects were instructed to brush their teeth twice a day with a fluoride-containing
dentifrice followed by a one-minute rinse with a chlorhexidine mouthrinse. Subjects were examined at baseline, 2 and 4 weeks for clinical indices and oral malodor.
Bacterial samples of dental plaque, saliva, and the dorsal tongue surface were assayed by culture on selective and non-selective media.
Results: After two weeks, all subjects had less oral malodor. Compared to baseline, there were significant reductions in both organoleptic scores and in mouth air
sulfur levels. The later was reduced from an average of 253 ppb to 107 ppb (p<0.0001) in the halitosis group and from 114 ppb to 51 ppb (p<0.0001) in the gingivitis
group. VSC-producing bacteria and total bacteria were significantly reduced from baseline (p<0.0001) in all three groups with the largest percent reduction in the
halitosis group followed by the gingivitis group and the normal group.
Conclusions: Organoleptic measures and mouth air sulfur levels were greatly reduced by two weeks of twice daily brushing with a fluoride-containing dentifrice
followed by a one-minute rinse with a chlorhexidine mouthrinse. The number of oral bacteria and VSC-producing bacteria were greatly reduced in dental plaque,
saliva, and on the dorsal tongue surface.
0474 (152213)
Treatment of oral halitosis: EO-containing mouthrinses
V.I. HARASZTHY
1
, and J.J. ZAMBON
2
|eo|e| o| CJo|o|o,. ec||o o| Co| /eJ|c|e. |||co| Co| ||,|o|o,. Co| |o||o|o, oJ ^o|o,. oe|oe. |eo|.
2
|e| o| ||eo| /eJ|c|e. ||.e||,
|o||o| ^oe. oe|oe. |eo|.
3
|e| o| CJo|o|o,. ||.e||, o| oe|oe. ec||o o| Co| /eJ|c|e. |||co| Co| ||,|o|o,. Co| |o||o|o, oJ ^o|o,.
oe|oe. |eo|
Objectives: To investigate whether the oral microflora in adults with celiac disease (CD) differs from that in healthy persons and to test if changes in the oral
microflora are associated with high caries experience and reduction in saliva flow rates.
Methods: Nineteen patients with CD (mean age 50.514.9 years, 15 women and 4 men) and 10 age- and gender matched healthy controls (47.816.8 years)
underwent an oral examination with registration of the DMFT/DMFS, plaque- and gingival indices, followed by measurement of unstimulated, paraffin-chewing-
stimulated whole saliva and citric-acid-stimulated parotid saliva flow rates, determination of salivary Streptococcus mutans and lactobacilli counts (Dentocult SM
Strip mutans and LB) and Candida smear from the dorsal part of the tongue.
Results: Unstimulated, chewing-stimulated and stimulated parotid saliva flow rates, DMFT/DMFS, plaque- and gingival indices did not differ between the CD patients
and the healthy controls. Streptococcus mutans and lactobacilli counts of more than 10.000 CFU/ml (colony forming unit/ml saliva) were more prevalent in patients
with CD than in the healthy controls (58% versus 20% and 53% versus 20%). Candida hyphae were found in 26% of the patients, but in none of the healthy controls.
Candida spores were present in 37% of the CD patients and in 20% of the healthy controls. DMFT/DMFS were associated with age in both groups, but nor with
salivary flow rates or bacterial counts.
Conclusion: Our results indicate that whole saliva and parotid saliva flow rates are not reduced in adults with CD and caries experience is not increased compared to
that of healthy controls. However, the patients showed higher counts of Streptococcus mutans and lactobacilli and a higher number of Candida hyphae which may
be ascribed to changes in the local and systemic immunological response to oral bacteria and fungi. The study was supported by the Danish Dental Association.
0480 (152291)
The Role of Stress in Bruxism- A Comparative Study
I. MONTEIRO
1
, S. FLIX
2
, and P.H. DUPAS
3
e|o Je |.e||ooo ||eJ|c|||o |o /o| (|||/:. ||||o|o oe|o Je |ec|o Jo ooJe |o /o|. ||oo. |o|oo|.
2
Co| |eo||||o||o. ||||o|o oe|o Je
|ec|o Jo ooJe |o /o|. ||oo. |o|oo|.
3
||.e||e ||||e 2 |o|| e| o|e. ||||e. |oce
Introduction: The role of stress, emotional and physical, in bruxism has been discussed for a long time. Stress and anxiety are implicated in its etiology, in addition to
precipitating, stress is also reported as predisposing and maintenance factor of bruxism and the prevalence of stress in individuals with bruxism is significantly higher
when compared with patients without bruxism.
Objectives: Analysis of the relationship of results of clinical features and anxiety in bruxism, comparing them, similarly, with two different groups, the stress group and
the general population group.
Material and Methods: Comparative cross-sectional study in a non-randomized sample of 45 individuals; the experimental group (bruxism diagnosis, n = 15), the
control group 1 (group of Stress - diagnosis of Anxiety Disorder, n = 15) and control group 2 (general population, n = 15). Beyond the Clinical Evaluation (intra and
extra-oral objective examination and functional examination; X-Ray examination; BruxChecker) the Characterization Questionnaire, Symptom Questionnaire (S. - SCL)
and Rating Scale Hamilton Anxiety (HAMA) were used. Statistical procedures were performed using the Statistical Package for Social Sciences - SPSS 18 software.
Results: Diagnosis of bruxism (sleep, daytime or daytime and sleep) in 84.4% of the total sample. Statistically significant results and a positive correlation between the
variables severity of bruxism, dental wear, general, physical and emotional anxiety symptoms.
Conclusions: Regardless of the group, with a previous diagnosis of Bruxism or Anxiety Disorder or not, bruxism is present in most of the sample study, however, with
varying degrees of severity and frequency of the clinical features analyzed. Individuals with bruxism differ from those with anxiety disorder, not by the clinical signs
and symptoms manifested, but rather by their severity. There is a significant positive association of stress and anxiety with bruxism, their contributing role, in
maintaining and / or aggravation.
0481 (152302)
Analgesic and healing effects of diode laser on recurring aphthosis
I. VOZZA
1
, M. DI LIETO
2
, A. QUARANTA
2
, and T. DI CARLO
2
|eo|e| o| Co| /eJ|c|e|o||o|o,. c|oo| o| |e|||,. ||.e||, o| |eo|o||| (^||:. |eo|o|||. Oeece.
2
|eo|e| o| |oo|o, oJ |||ocoo||||||,.
||o|o|e|o |o||o| o| |eo|o|||. |eo|o|||. Oeece
Objectives: Genetic alterations of the immune-response mediators, cytokines may strongly implicate in the pathogenesis of oral lichen planus (OLP). The aim of the
present study was to investigate the prevalence of Tumor Necrosis Factor-a (F-a) and Interferon-gamma (IFN-gamma) gene polymorphisms and haplotypes in OLP.
Methods: Gene polymorphisms and haplotypes of IFN-gamma +874, TNF-a -238, and TNF-a -308 were detected in 40 patients with confirmed OLP from Northern
Greece compare to 39 healthy individuals with similar age-gender characteristics. Cytokine typing was performed using the LIFECODES Cytokine-sequence-specific-
oligonucleotides-(SSOs)Typing Kit (GEN-PROBE Transplant Diagnostics, Inc) for polymerase chain reaction (PCR).
Results: No differences were found between OLP patients and controls for IFN-gamma +874 genotype distributions or A, T alleles frequencies (p=0.701), as well as
TNF-a -308 genotypes or A, G alleles frequencies (p=0.275). In contrast, significant differences were observed in the frequencies of A/G, G/G genotypes (p=0.0001)
and A, G alleles (p=0.0002) in TNF-a -238 position.
Conclusions: In contrast to researches for other ethnicities, this study suggests a strong association between gene polymorphism/haplotype in TNF-a -238 but not
TNF-a -308 in OLP patients of Northern Greece. Furthermore, according to our results, the IFN-gamma +874 is not implicated in the genetic background of Northern
Greek OLP-patients.
0489 (152203)
Antibacterial action of photoactivated desinfection (PAD) on endodontic bacteria
C. TENNERT, L. DISCHINGER, M. ALTENBURGER, and K. WRBAS
|eo|e| o| Ceo||.e |e|||, oJ |e|oJo|o|o,. ||.e||, o| |e|o. ||.e||, /eJ|co| e|e. |e|o| c|oo| oJ |o||o|. |e|o. Oeo,
Objectives: To determine the antibacterial effect of photoactivated desinfection (PAD) on Enterococcus faecalis biofilms in experimentally infected root canals.
Methods: 50 single-rooted extracted teeth with one root canal were flared using Revo-S instruments (size 25, 0.06 taper). Teeth were autoclaved and infected with a
clinical isolate of E. faecalis for three days. Samples were taken using paper points to determine the presence of E. faecalis in the root canals. For the antimicrobial
treatment the teeth were devided into two groups. In the first group teeth were treated using the PAD system (Aseptim Plus, SciCan, Germany), consisting of the
photosensitizer Aseptim Solution, a tolonium chloride solution and the PAD light source at 635 nm and sampled with paper points. Teeth were treated with Aseptim
Solution and the PAD light source for a second time and sampled. In the second group root canals were rinsed with 5 ml of 20% citric acid. After sampling with paper
133
points, root canals were treated with Aseptim Solution and the PAD light source. Another sample was taken. Survival fractions of the samples were calculated by
culturing on blood agar and counting colony-forming units.
Results: Treatment of root canals with PAD alone caused a reduction of bacterial load, resulting in a 76,6% kill of E. faecalis. A repeated PAD treatment killed 95,9% of E.
faecalis. Rinsing root canals with 20% citric acid achieved a reduction of 93,7% and the combination of 20% citric acid irrigation and PAD reduced bacterial viability by
97,3%.
Conclusion: Photoactivated desinfection killed E. faecalis in human root canals. A second application of PAD leads to a more effective desinfection. PAD is not an
alternative but a possible supplement to existing protocols of root canal desinfection. Disruption of the biofilm prior to PAD remain mandatory for adequate root
canal desinfection. >
0490 (151282)
Can masseter stiffness become an index for evaluating massage treatment?
Y. ARIJI
1
, Y. HIRAIWA
1
, Y. KISE
1
, S. SAKUMA
2
, A. KATSUMATA
3
, and E. ARIJI
1
|eo|e| o| Co| oJ /o|||o|oc|o| |oJ|o|o,. ^|c||Oo|o| ||.e||, c|oo| o| |e|||,. |oo,o. .oo.
2
|eo|e| o| ||eJ |o||oJo||c c|oo| o| |e|||,. ^|c||
Oo|o| ||.e||, c|oo| o| |e|||,. |oo,o. .oo.
3
|eo|e| o| Co| |oJ|o|o,. ^o|| ||.e||, c|oo| o| |e|||,. |oo|. .oo
Objective: To examine the masseter stiffness, the masseter thickness and the maximum occlusal force in patients with myofascial pain, and to analyze their changes
after massage treatment.
Materials and Methods: Sixteen patients with temporomandibular joint dysfunction with myofascial pain were enrolled in this study. Their age ranged from 26 to 69
years, and the median age was 41 years. They were informed of the aim of the study, and provided their consents before participating. Four male and 8 female
patients had the unilateral masseter pain, and the 4 female patients had suffered the bilateral masseter pain. The stiffness of the bilateral masseter muscles were
measured using NEUTONTDM-N1. The thickness of the bilateral masseter muscles were measured on sonographic images with LOGIQ E9. Elastograhic images were
taken together. The maximum occlusal force was measured on the bilateral first molars using Occlusal Force Meter GM10. All patients undertook the massage
treatment using a specially fabricated robot (WAO-1). After massage treatment, the masseter stiffness, the masseter thickness and the maximum occlusal force were
measured.
Results: In patients with the unilateral masseter pain, the masseter stiffness of the symptomatic side was larger than those of the contralateral side (p<0.05). In
patients with the bilateral pain, there was a significant right-and-left difference (p<0.05). There were no significant right-and-left difference in the masseter thickness
and the maximum occlusal force. After massage treatment, VAS score of pain decreased. The masseter stiffness and thickness significantly decreased and the
maximum occlusion force significantly increased (p<0.01). Sonographic elastographic images before and after the treatment were presented.
Conclusion: The masseter stiffness in patients with myofascial pain had a significant laterality, and it significantly decreased after the massage treatment. Therefore,
the masseter stiffness may have the possibility of an index for evaluating therapeutic gain.
0491 (151305)
NewAdjunct Test for Oral Malodour: Pre Clinical Validation
J. DADAMIO
1
, S. VAN DENVELDE
1
, M. VANTOURNOUT
1
, F. VANCAUWENBERGHE
1
, C. DECKEYSER
1
, R. FREDERICO
2
, and M. QUIRYNEN
1
|eo|e| o| |e|oo||.e |e|||, oJ |e|oJo||c. ||o /o| ||.e||,. ||o /o|. |o||oJ.
2
||o /o| ||.e||,. ||o /o|. |o||oJ
Purpose: The aim of this study was to evaluate the effect of 2% chlorhexidine compared with saline solution on the outcome of pulpectomy in primary molars.
Methods: Sixty-four mandibular primary molars from 40 children (average age 5.51.3 years) met the inclusion criteria. Chlorhexidine or Saline solution was allocated
to each tooth by stratified randomization. A 1-visit pulpectomy and stainless steel crown was performed by 1 investigator. The clinical and radiographic diagnoses
were blindly assessed by 2 calibrated investigators.
Results: At 6 months, the overall success rates were 100% for chlorhexidine group and 83.3% for saline solution. At 12 months, the overall success rates were 96% and
100% for chlorhexidine and saline solution groups, respectively. Using chi-square test, the outcomes were significantly different at 6 months, but not significant at 12
months.
Conclusion: Outcome of pulpectomy in primary molars might be enhanced by the use of 2% chlorhexidine at 6 months. Both irrigants gave comparable results at a
longer period of time. (This study was supported by funding from the faculty of Dentistry, Chiang Mai University, THAILAND.)
0498 (151401)
NewAdjunct Test for Oral Malodour: Clinical Utility
F. VANCAUWENBERGHE
1
, J. DADAMIO
1
, M. VANTORNOUT
1
, S. VAN DENVELDE
1
, C. DECKEYSER
1
, R. FREDERICO
2
, and M. QUIRYNEN
1
|eo|e| o| |e|||,. Co| oJ /o|||o|oc|o| oe,. ||.e||, o| |ec |e|o| c|oo|. |ec. |oo,.
2
||.e||, o| |ec. |oco||, o| |eo||| c|ece. |ec. |oo,
Objectives: The working length determination is carried out before the root canal preparation. We investigated the difference between hand instrumentation and
preparation with nickel-titanium rotary instruments, how the praeoperative defined working length was respected, and the possibility of length changes when using
larger instruments.
Methods: By forty extracted upper molars the working length of the mesiobuccal root canal was estimated, and the teeth were fixed in acryl blocks integrated in a
mandibular arch model at the corresponding anatomical position in a dummy head. The root canal preparation was carried out in 1. group (n=20) with hand
preparation (K-files, VDW, Munich, Germany) and in 2. group (n=20) with nickel-titanium rotary instrument (Mtwo, VDW, Munich, Germany). Vestibulo-oral and mesio-
distal directional x-ray images were taken from each sample before the preparation with #10 K-file, inserted into the mesiobuccal root canal to the working length,
and after preparation with #25, #30 and #40 files which were used during the enlargement of the canals. The distances between the radiological apex and the
instruments were measured and compared to the distances measured on the praeoperative X-ray image.
Results: There was significant difference (p<0.05) in the 2. group between measurements with #10 and # 40 files only on the vestibulo-oral x-ray images, while in the
1. group all three sizes show significant differences in both x-ray images (p<0.05) (ANOVA). With regression analysis we found by the hand instruments a significant
trend of work length shortening, with a mean of 0.022mm increase of the radiographic apex-instrument distance ( p<0.01) in relation to the size of instruments used.
In the rotary prepared group the increase of distances shows neither significant regression nor linear relation.
Conclusion: We found that using nickel-titanium rotary instruments the estimated working length strictly respected, what could notably contribute to more
successful therapeutic intervention.
136
0501 (151987)
Development of real 3Ddental X-ray
G. BERKEI
1
, P. KIS
1
, M. GYURKOVICS
2
, I. STUBER
3
, C. KOROM
4
, and Z. LOHINAI
2
/o|||o|oc|o| |oJ|o|o,. |oo||o ||.e||, OoJoo|e c|oo| o| /eJ|co| oJ |e|o| c|ece. |oo||o. .oo.
2
/o|||o|oc|o| ||oo||c oJ o|co| c|ece.
|oo||o ||.e||, OoJoo|e c|oo| o| /eJ|co| oJ |e|o| c|ece. |oo||o. .oo
Objectives: Nuclear agents of 18-F-FDG (18-F-fluorodeoxyglucose, PET), 201-TlCl (201-thallium-chloride) and 99m-Tc-MIBI (99m-technetium-
hexakismethoxyisobutylisonitrile) are used in dentistry. Uptake and discharge of them in tumor cells are controlled in large part by transport proteins expressed on
cell membrane; glucose transporter (Glut) is for 18-F-FDG, Na/K-ATPase is for 201-TlCl and permeability glycoprotein (P-gp) is for 99m-Tc-MIBI. Moreover, L-amino-acid
transporter-1 (LAT-1) has attracted special interest recently for amino-acid labeled nuclear agent. They tend to show a stronger expression in malignant tumor. The
purpose of this presentation is to estimate the usefulness of transport proteins as malignant tumor marker.
137
Materials and Methods: Patients with oral cancer underwent scintigraphy with 18-F-FDG, 201-TlCl or 99m-Tc-MIBI. From scintigraphy with 201-TlCl or 99m-Tc-MIBI,
tumor retention index (accumulation degree) was obtained, and SUV (standard-uptake-value) was gained from FDG-PET. Expression of transport proteins was
evaluated immunohistochemically. Transport proteins were estimated in relation with the tumor retention index, SUV and histopathological tissue differentiation.
Benign salivary gland tumor was used as a control.
Results: Transport proteins were found in malignant tumor more than in benign tumor, and the tendency was also distinct in relation with tissue differentiation. 201-
TlCl showed a larger tumor retention index in malignant tumor than benign tumor. This means that Na/K-ATPase works as a transporter to incorporate 201-TlCl into
tumor cells. On the contrary, 99m-Tc-MIBI showed a smaller tumor retention index in malignant tumor. This means that P-gp pumps 99m-Tc-MIBI out from tumor cells
that was once accumulated inside cells. FDG-PET showed an apparent SUV in malignant tumor. This means that Glut helps 18-F-FDG to go into tumor cells. LAT-1 also
showed a higher expression in malignant tumor.
Conclusion: Each transport protein has a possibility to be a malignant tumor marker and is surely useful for differentiating malignant tumor from benign tumor. We
are trying to separate transporters from saliva.
0505 (152191)
Dental rehabilitation for children with disabilities under general anesthesia
N. RZSA
1
, P. STEINBACH
2
, V. KOVCS
1
, I. SIMON
1
, G. LISZKAY
3
, and I. TARJN
1
e|o|o, o| /o|e|o| oJ |e.|ce | |e|o| /eJ|c|e. ||.e||, o| /eJ|c|e oJ ||ooc, v|c|o |oe. ||ooo. |oo|o.
2
|eeoc| |e.e|oe|. |\ |o|J| ^. |o
|ooJe|oJ. .||e|oJ
Objectives: The objective of this study is to assess the quality of Co-Cr prosthetic restorations, obtained with the laser sintering technique.
Methods: Selective laser sintering technique uses a high power CO2 laser to fuse small particles of metal powders into a mass representing a desired 3-dimensional
object. The laser selectively fuses metal powders by scanning cross-sections generated from a 3-D digital description by CAD file. After each cross-section is scanned,
the powder bed is lowered by one layer thickness, a new layer of material is applied on top, and the process is repeated until the part is completed. The topography
of the dental restoration is designed by numerical monitoring after having scanned devised prostheses. In our application the alloy consists of 64-67% Co, 28-30% Cr
and 5-6% Mo, and has at equilibrium of a &gamma monophasic structure. Evaluation and characterisation was made by: Microstructure analysis; Corrosion resistance
evaluation; Polarization test; Crevice corrosion test; Release of cations.
139
Results: Dimensional observations of Co-Cr restorations show that adjustment leads to satisfactory clinical results with a precision of 25&mu m. The average hardness
is 395HV, comparable to metallo-ceramic elements obtained by casting technique. The metallographic observations show a slight porosity in the sintering plane.
Punctual analysis shows a high regularity of the local chemical composition: 62.6-64%Co, 29.3-30.5%Cr and 4.9-6.4%Mo. Potentiodynamic polarization curves confirm
the presence of the porosity in the structure of the restoration. SEM micrograph of the corroded surface after the polarization test shows: O 24.53, Na 1.19, Si 1.12, Cl
0.59, Cr 28.76, Co 34.30, Mo 9.52.
Conclusion: The technique of manufacturing by selective laser sintering allows obtaining prosthetic elements of high dimensional precision which present
mechanical properties in agreement with the clinical requirements. However, the residual porosity inherent to the sintering process may present a risk for fracture and
crevice corrosion.
0511 (151355)
Treatment alternatives to substitute upper lateral incisors: 10-year preclinical loading
R. TUNJAN
1
, M. ROSENTRITT
2
, C. HOHMANN
3
, G. STERZENBACH
1
, R. SEEMANN
4
, and M. NAUMANN
5
|e| o| |o||oJo||c. Oe|o||c |e|||, oJ o|ooJ|o|o ||oJe. |o||e ||.e||, o| |e||. |e||. Oeo,.
2
|eo|e| o| |o||e||c |e|||,. ||.e||,
/eJ|co| e|e |eeo. |eeo. Oeo,.
3
||.o|e |e|o| C|||ce. |e||. Oeo,.
4
||.e||, o| |e. |o|o. Oeo,.
5
|e| o| |o||e||c |e|||,. ||.e||, o|
||. ||. Oeo,
Objectives: to evaluate the survival of zirconia-based treatment alternatives when an upper lateral incisor is missing and a 10-yr simulation by thermomechanical
loading (TML) was applied.
Methods: Human upper, central incisors were randomly assigned to 4 groups (n=8). Teeth were endodontically treated and restored as follows: (I) access cavity filled
with composite, preparation according all-ceramic requirements, crowns with zirconia frame work (ZF) and one cantilever unit were adhesively placed, (II) as (I) but an
one-wing resin-based cantilever FPD (RB-FPD) with ZF was adhesively placed, (III) specimens were cut 2 mm above cemento-enamel junction, composite-resin core
build-up, final restoration as (I), (IV) specimens as in (III) built up, but an additional fibre post was inserted. (V) implant with all-ceramic abutment restored as in (I). To
simulate 5 years of clinical function specimens were subjected to TML (1.2*10 -6 load cycles 1 49 N; 6000 thermocycles 5/55 C). If specimens survived this interval
another TML interval was added. Kaplan-Meier curves were constructed and Log-rank tests performed (p = 0.05).
Results: Most events were observed in (I): 25% tooth fracture, 25% debonding with chipping; (II) 50% debonding only, 13 % debonding with chipping; (III) and (V)
25% of specimens failed by chipping, respectively, (IV) only 13% showed chipping. No significant differences were found regarding survival (p=0.162), but regarding
failure patterns (Fisher' exact test: p=0.005).
Conclusions: After 10 years of preclinical TML all evaluated treatment alternatives appear recommendable to substitute an upper, lateral incisor. However, fibre-post
supported restoration revealed the lowest number of failures.
0512 (151482)
In-vitro Study of the Fracture Resistance of Implant-supported All-ceramic Restorations
A. FERREIROA
1
, F. MARTNEZ-RUS
1
, J.F. BARTOLOM
2
, and G. PRADES
1
|eo|e| o| |occo|oc|o| |o||e|. |oco||, o| CJo|o|o, ||.e||, o|o|ee o| /oJ|J. /oJ|J. o|.
2
|eo|e| o| ||oo|e|o| oJ ||o||eJ /o|e|o|.
/o|e|o| c|ece ||||o|e o| /oJ|J o|| |o||oo| |eeoc| ooc||. o|o|oco (/oJ|J:. o|
Objectives: The purpose of this investigation was to evaluate the fracture resistance of implanted-supported zirconia and titanium abutments restored with glass-
ceramic and zirconia-based ceramic crowns.
Methods: Using the Straumann CARES CAD/CAM technology, two groups of implant abutments were fabricated for the Straumann implant system (n=30): zirconia
abutments (Z), and titanium abutments (T). All abutments were generated from the same STL file. Standardized maxillary central incisor all-ceramic crowns (n=10)
were fabricated for the zirconia and titanium abutments using the following systems: heat-pressable lithium disilicate glass-ceramic (IPS e.max Press) (Zp and Tp),
machinable lithium disilicate glass-ceramic (IPS e.max CAD) (Zc and Tc), and zirconia based-ceramic (IPS e.max ZirCAD) (Zz and Tz). The crowns were cemented to the
implant abutments with a resin luting agent (Multilink Implant). Afterwards, all specimens were tested for fracture resistance according to the ISO norm 14801. Data
were analyzed using two-way ANOVA and Tukey post hoc tests ( = .05).
Results: The mean fracture load values were 363 50.5 N for group Zp, 482.2 58.4 N for group Tp, 392.9 55.3 N for group Zc, 558.5 35.2 N for group Tc, 340.3
61.8 N for group Zz, and 495.9 53.4 N for group Tz. ANOVA detected significant differences with respect to implant abutment, all-ceramic restoration, and the
interaction of the two factors (p = .0001). Titanium abutments showed significantly higher fracture loads than zirconia abutments (p = .0001). Zirconia ceramic crowns
presented the lowest fracture resistance, revealing significant differences with respect to the glass-ceramic crowns (p = .0001).
Conclusions: The type of abutment and all-ceramic crown system significantly influenced the strength of single-tooth implant-supported all-ceramic restorations.
Titanium abutments restored with machinable lithium disilicate exhibited the highest fracture load values.
0513 (151511)
CADCAM: a method for assessing mechanical behavior of ceramic crowns
M. FAGES
1
, S. CORN
2
, J. RAYNAL
1
, P. SLANGEN
3
, P. IENNY
3
, P. RIOU
2
, J. MARGERIT
1
, and F. CUISINIER
1
|eo|e| o| Ceo||.e |e|||, oJ |e|oJo|o|o,. ||.e||, /eJ|co| e|e |e|o. |e|o| c|oo| oJ |o||o|. |e|o. Oeo,.
2
|eo|e| o| Co|
||o|ec|o|o,. ||.e||, /eJ|co| e|e |e|o. |e|o| c|oo| oJ |o||o|. |e|o. Oeo,.
3
|eo|e| o| |.|oe|o| |eo||| c|ece. ||.e||, /eJ|co| e|e
|e|o. |e|o| c|oo| oJ |o||o|. |e|o. Oeo,
Objectives: The aim of the present study was to evaluate the elution of substances from a silorane composite and its effect of immortalized human gingival
keratinocytes (IHGK).
Methods: FiltekTM Silorane (FS) was tested. For the analysis, 20 specimens (diameter 4.5 mm and 2 mm thickness) were prepared. 10 specimens were stored in
human saliva and 10 in ethanol 75%, for 24 h, 7 days and 28 days. From the storage medium removed, solution samples were prepared for the analysis and they were
scanned using SIM (scanning ion monitoring) for any masses between 100 and 1000. For testing the cell effects IHGK, immortalized with the HPV-16 E6/E7
oncogenes, were used and propagated under standardized cell culture conditions. 20 composite samples were prepared and were immersed separately in cell
culture medium. Ten samples were stored in a dark box for 24 h and the other ten for 4 days. Subsequently, the solution was placed on IHGKs, for 24h or 4 days
respectively, and incubated at 37 degrees. Additionally, IHGKs were cultivated in native medium as controls. After cultivation, the total RNA was isolated and RNA
concentration was measured. Moreover, IHGKs from each group were subjected to Annexin-5 staining procedure and documented by fluorescence microscopy.
Results: Two different masses were detected (393, 337), after 28 days storage in human saliva and after storage in ethanol 75% independently of the storage time.
The RNA concentration measured in the FS group was lower than the one in the control group, at both tested times (24h: control:302ng/ml, FS: 128ng/ml, 4days:
control:528ng/ml, FS:162ng/ml). The fluorescence images revealed cell apoptosis.
Conclusions: Two different masses, corresponding to silorane monomers, were found to be eluted. FS showed a reduction of the RNA amount of IHGKs after 24h and
4 days indicating some severe effects on cell viability.
0523 (151327)
The Role of Glutathione in HEMA-induced Apoptotic Cell Death
S. KRIFKA
1
, K.-A. HILLER
1
, C. BOLAY
1
, C. WAHA
1
, G. SPAGNUOLO
2
, G. SCHMALZ
1
, and H. SCHWEIKL
1
|eo|e| o| |eco|oc||.e oJ ||oo||c o|co| c|ece. C||oJo||c |eo|e| || |oJo|oe CeJo|e /o|oe |o||c||. ||.e||, o| /||oo. /||oo. ||o|,.
2
|eo|e| o| Co| oJ /o|||o|oc|o| oe,. ee|.e| ||.e||, o| /eJ|c|e. |oJoe|. |oo,
Aim: To examine the relationship between the clinical signs and symptoms of temporomandibular joint disorders and Cone Beam Computed Tomography (CBCT)
evidence of destruction of these joints in children afflicted with Juvenile Idiopathic Arthritis (JIA). It has been evaluated from a statistical stand point the temporal,
metric and clinical variables of the disease, also measuring condylar and mandibular real volumes in order to plan an effective therapy.
Materials and Methods: This study enrolled 30 patients with JIA. CBCT has been performed. 3D quantitative measures of the mid-lateral and anterior-posterior
diameters and angles of the condyles were taken. The mandible was isolated from others craniofacial structures; the whole mandibular volume and its components'
volumes (condyle, ramus, emibody, emisymphysis on right side and on left side) has been calculated by a 3D volume rendering technique.
Results: The analysis of the condylar changes showed that the most apparent signs were the erosion (44%), the flattening (24.5%) and the presence of osteophytes
(15%). Only 2% of the study subjects had no damage. There was a very significant difference in the linear and angular measurements between healthy and affected
condyles (p<0.01). The results show a highly significant statistical difference between affected side volumetric values versus normal side volumetric values above all
on condyle region (P<0.01), while they doesn't show any statistical differences between right side versus left side.
Conclusions: CBCT represents an improvement in quantifying the morphological changes of the condyle and mandible, gives an accurate picture of these structures
in JIA and allows the acquisition of true measurements of the mandibular components even in the early stages of JIA. Early initiation and optimal adjustment of
aggressive therapy with disease-modifying anti-rheumatic drugs have been extremely successful in preventing irreversible joint damage.
0530 (151932)
Genetic Determinants of Tooth Agenesis in the Hungarian Population
G. JOBBGY-OVARI
1
, C. PSKA
1
, P. STIEDL
1
, D. HONTVRI
1
, B. TRIMMEL
1
, B. SOS
2
, P. HERMANN
2
, Z. TTH
3
, M. MARTONOSI
4
, I. SZNT
5
, . NAGY
5
, D. NAGY
5
,
B. KEREKES-MTH
6
, . HADADI
7
, C. SZALAI
7
, G. HULLM
8
, G. TEMESI
8
, P. ANTAL
8
, M. MADLNA
9
, I. TARJN
9
, and G. VARGA
1
|eo|e| o| |e|||,. Co| oJ /o|||o|oc|o| oe,. |ec. |oo,. ||.e||, o| |ec /eJ|co| c|oo|. |ec. |oo,.
2
|eo|e| o| ||oc|e||, oJ /eJ|co| |e||,.
|ec. |oo,. ||.e||, o| |ec /eJ|co| c|oo|. |ec. |oo,.
3
|eo|e| o| ||oc|e||, oJ /eJ|co| |e||,. ||.e||, o| |ec /eJ|co| c|oo|. |ec. |oo,
Objectives: Globally, oral and pharyngeal cancer represents the sixth leading cancer site. Among European countries, mortality rate is highest in Hungary. Early
detection could reduce its associated morbidity and mortality. Changes in protein abundance, structure and function are indicators of abnormality before possible
development of clinical symptoms and malignancy. Thus their diagnostic and prognostic value as biomarkers is of high importance.
Methods: Human whole saliva can be obtained in a noninvasive way and proteins derived from the living cancer cells can be obtained easily. The proteomic
approach yields to provide identification of possible biomarkers for early detection.
Results: Our study compared whole saliva specimen from healthy, precancerous, cancerous and post therapy cancer patients.
Conclusion: Differences in protein patterns could be seen with MALDI/TOF system and might lead to promising candidates of significant diagnostic and therapeutic
value.
0536 (151614)
Implant Site Development by Orthodontic Extrusion for Immediate Implant Placement
D. BLASE, J. LASSERRE, S. TOMA, P. BERCY, and M. BRECX
|eo|e| o| |e|oJo|o|o,. ||.e||e o||o||oe Je |oo.o|. |oe|. |e||o
Recession of the mid-vestibular mucosa is a common aesthetical complication with immediate implant placement (type 1).
Objectives: The aims of the study were to evaluate 1. if implant site development by orthodontic extrusion of nonrestorable teeth can create a keratinised mucosa
surplus to compensate mid-vestibular mucosa recession following immediate implant placement 2. One year implant survival rate
Methods: Twenty patients were recruited with a nonrestorable tooth in the aesthetic zone: the marginal gingival level was more apical or at the same level as the
adjacent teeth. Orthodontic extrusion was performed within 3 months using 2 or 3 adjacent teeth as anchorage. The tooth was carefully extracted . Flapless immediate
implant placement was performed using Straumann SLActive Bone Level Implant ( Regular Crossfit or Roxolid Narrow Crossfit). Immediate temporization was
performed with screw retained resin crown within 24 hours. Final screw retained full ceramic restoration on zirconium framework ( Etkon system ) was placed 3 months
after implant placement (conventional loading). The main followed parameters were the implant survival rate and the height of mid-vestibular keratinized mucosa.
Results: The orthodontic extrusion increased the height of mid-facial keratinized mucosa by 2.8 0.7 mm. The mean recession 1 year after implant placement was 2
0.6 mm. At 1 year, there was no implant loss, no aesthetical complaints, no biological complication and only 1 temporary crown veneer fracture (5% technical
complication).
Conclusions: Implant site development by orthodontic extrusion seems to be a reliable therapeutic alternative to increase the height of keratinized mucosa and
therefore compensate mid-vestibular recession following immediate implant placement. A longer follow up is needed to evaluate the stability of these results.
0537 (151577)
Systemic and local inflammatory responses in various experimental periodontitis models
K. SAADI-THIERS
1
, O. HUCK
1
, P. SIMONIS
1
, H. TENENBAUM
1
, P. TILLY
2
, J.E. FABRE
2
, and J.-L. DAVIDEAU
1
|eo|e| o| |e|oJo|o|o,. Oo| ||.e||, |oco||, o| |e|||, |eo|e| o| |e|oJo|o|o,. ^|oo. o|e,.
2
Oo| ||.e||e|. ^|oo. o|e,
Aim: The aim of this study was to compare the level of proinflammatory cytokines (PICs); including interleukin-1beta (IL-1), interleukin-6 (IL-6), and tumor necrosis
factor-alpha (TNF-) in gingival crevicular fluid (GCF) during orthodontic tooth movement.
Materials & Methods: Ten orthodontic patients (13-14years old) having different Angle classifications received professional prophylaxis and oral hygiene instructions
prior to orthodontic treatment. After first premolar extractions, canines were randomly divided two groups. 19 right canines were distalized by hybrid retractor with
150g, while PG retractors applying 100g were used for the distalization of 18 left canines. Plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment
level (CAL) and bleeding on probing (BOP) were recorded. GCF was sampled from distal gingival crevices of each canine at baseline (pretreatment), 1 hour, 24 hours, 7
and 28 days after the application of orthodontic forces. During the examination periods no orthodontic activation was performed. IL-1, IL-6, and TNF- levels in GCF
were measured by enzyme-linked immunosorbent assay (ELISA). Repeated ANOVA, Mann-Whitney U test and Spearman rank correlation analysis were used.
Results: The levels of IL-1, IL-6 and TNF- were significantly increased in both groups at 24 hours (p<0.05). Later both groups declared significant decreases at day-7
and 28. Intergroup differences revealed significantly higher values in the hybrid retractor group at 1 hour.
Conclusions: The local host response toward the orthodontic forces lead an increase in PICs in the early stages of inflammation, which may be one of the triggers for bone
remodeling processes. The initial continuous force caused cytokines to increase significantly after one hour; therefore the importance of initial force can not be neglected.
0540 (152240)
Diabetic intervention and its role on early neutrophil (PMN) signaling
J.M. HERRMANN, J.P. LIPPERT, and J. MEYLE
|e|oJo|o|o,. .o|o ||e| ||.e||,. O|ee. Oeo,
Improved diabetic conditions were reported, when periodontal treatment accompanied systemic and metabolic intervention. Altered neutrophil (PMN) functions
may contribute to local tissue damage and the deterioration of systemic parameters. Cellular (pre-) activation during host response is primarily receptor dependent.
Therefore, the objective: of the study presented here was to investigate chemoattractant (FP-R) as well as immunoglobulin (Fc-R) receptor mediated PMN signaling
activation prior and after a regimen of diabetic intervention.
Methods: In this prospective ex vivo study 24 individuals participated after giving their written informed consent. Peripheral blood PMN from diabetics and age- and
gender matched controls were isolated by dextran as well as Ficoll protocol. PMN were loaded with membrane permeant probes BCECF for cytosolic pH (pHi)
and/or Indo-1-AM for cytosolic Ca2+ concentration ([Ca2+]i). PMN receptor agonists N-formyl-Met-Leu-Phe (fMLF) and/or high valency immune complex (HIC) were
employed for stimulation of early cytosolic signaling functions and measured in a Hitachi F-7000 fluorimeter (Binninger-Analytik, Germany). Systemic parameters of
diabetic and inflammatory controls as well as periodontal status (Florida Probe) were monitored.
Results: Resting [Ca2+]i dropped (ANOVA, p<0.05) and altered cytosolic signaling [Ca2+]i as well as pHi prior to intervention reached control levels after patients had
undergone anti-diabetic medication, dietetic monitoring and physical exercises during a 2 to 3 weeks of hospitalization (ANOVA, p<0.01). When compared to FP-R
responses Fc-R agonist HIC lead to attenuated but elongated signaling (Kruskal-Wallis, p<0.01).
Conclusions: On a receptor mediated level, anti-diabetic treatment may help to normalize diabetes induced PMN cytosolic signaling alterations. In addition, these
data suggest the importance of synergistic periodontal and anti-diabetic treatment regimens for diabetes mellitus patients suffering from periodontitis.
0541 (152304)
Effect of mouthrinses in a subgingival-biofilmmodel by ATP bioluminescence
E. FIGUERO
1
, M.C. SNCHEZ-BELTRN
2
, M.A. LLAMA-PALACIOS
3
, M.J. MARN-CUENDA
3
, V. BLANC
4
, R. LEN
4
, D. HERRERA
5
, and M. SANZ
5
|e.e||.e oJ e|oo||.e Jeo|e| o| /oe|||e. /eJ||eoeo ||.e||,. ||o|oo |ooo|o, |^ 4203. /o|e|||e eJe 5. |oce.
2
|e.e||.e oJ e|oo||.e
Jeo|e| o| /oe|||e. /eJ||eoeo ||.e||,. ||. |ooo|o|e |o|e oo|o |/| 522. /o|e|||e eJe 5. |oce.
3
|eo|ee| e|coJoc|eo. /o|e|oo e|
o|eo. /o|e|||e ||.ec||, 2. |ooo|o|e |o|e oo|o |/| 522. /o|e|||e. |oce
Non-linear optical microscopy (NLOM) is an effective method to follow pathological processes involving collagen fibrosis or collagen destruction. In particular, the
intensity of the second harmonic generation (SHG) signal depends on the structure and orientation of the collagen fibers. In this work, we have used two-photon
fluorescence (2PEF) and SHG to investigate the dental caries process. The objective of this study is the characterization of the collagen network in sound and carious
dentin using NLOM to study non decalcified teeth. Materials and methods: Longitudinal slices with thickness up to 0.5mm were prepared from freshly extracted
teeth: 4 from a sound tooth without caries and 4 from a carious tooth. The samples were polished to 0.25 m and cleaned up in an ultrasound alcohol bath for 5 min.
Fluorescence microscopy, at a wavelength of 480nm, was performed on sound and carious dentin structures. Dentin collagen network images were provided by
means of 2PEF and SHG, using an incident wavelength of 800nm on areas previously defined by fluorescence microscopy. Results and conclusion: We have visualized
groups of collagen fibres that are constituents of the healthy dentin extracellular matrix and succeeded to differentiate between healthy and carious tooth dentin
structure. In a carious lesion, the SHG signal is low and the collagen network is difficult to observe. The obtained 2PEF and SHG three-dimensional images of dentine
reveal the tubule network. The visualization of the three dimensional structure of the samples and the optical sectioning capacity inherent to the NLOM technique is
a powerful approach for non-invasive investigation of dentine structure and caries.
0552 (153524)
In-vivo Mimicking of Caries: AWay to Understand the Origin of Fluorescence
F. CUISINIER
|^ 4203 |ooo|o, o| ||o|o, oJ |ooc|ece. |oco||, o| CJo|o|o,. /o|e|||e. |oce
Our aim was to determine the origin of the fluorescence of dental tissues observed with the Soprolife camera during caries. We have conducted in-vitro studies to
evaluate the origin of fluorescence using acid and MMP to mimic caries and methylglycoxal (MGO) to evaluate the effect of glycation reaction on final red
fluorescence. The red color of carious dentin using Soprolife camera is corresponding to the brownish are observed using day light. Demineralization using nitric acid
induces a loss of the green fluorescence of dentine. The red color of carious dentin is resisting to acid treatment. Immersions of demineralized dentin in MGO
solutions induce a change of color from white to orange red. After two additional weeks in MGO the tooth section is homogenously red. This is indicating that the
Maillard reaction contributes to lesion coloration. The immersion of demineralized dentin in an MMP-1 solution followed by the same treatment with MGO appear to
give a similar color.
0553 (153525)
Survey of Caries Detection Methods
O. BREDE
|e|oJo|o|o,. Ceo||.e oJ |e.e||.e |e|||,. ||.e||, o| |o. |o. Oeo,
Laser fluorescence measurements have been shown to be well suited for both caries and calculus diagnosis. Thus, the SoproLife system with an excitation
wavelength of 405nm should be comared to different laser fluorescence devices for caries and calculus detection.
We could observe that the SoproLife system can differentiate a carious lesion involving enamel and superficial dentine caries as well as a demineralization involving
the middle third of dentine, improving the diagnosis by visual criteria. Thus, studies indicate that the novel laser fluorescence device seems to be suitable for occlusal
caries diagnosis.
In previous studies, a novel fissure sealant seems to be promising with respect to control caries progression underneath the sealing material. Especially the visual
output of camera based fluorescence devices might offer an easily usable possibility of long term caries monitoring and avoid unnecessary excavation procedures.
With respect to periodontal diagnosis, we can observe that fluorescence of calculus is significantly higher compared to the fluorescence of cement. A differentiation
using intensity values is possible as well as considering the spectrum. Using a wavelength of 405nm, both methods are suitable to distinguish calculus from cement
and could be used in further devices, improving minimal invasive possibilities of periodontal diagnostics.
In general, the use of a 405 nm excitation wavelength might be a useful adjunctive tool for caries and calculus diagnosis.
0554 (153526)
Dental Caries Classifications and Clinical Applications of Fluorescence-Based Methods
H. TASSERY
|e.e||.e oJ e|oo||.e Jeo|e| o| /oe|||e. /eJ||eoeo ||.e||,. ||o|oo |ooo|o, |^ 4203. /o|e|||e eJe 5. |oce
A medical approach of determining the patient's caries risk via a Cariogram, CAMBRA or MITP is needed for up to date dentistry with lot of previous and new caries
classifications available: e.g Ekstrand, Hume and Mount, UniViss, ICDAS. But whatever the classifications or medical concepts used, the threshold of intervention seems
to be whether there is a cavitated lesion and the remaining clinical question is still : drill or not drill in addition to the clinical sequence : sealing, drilling and
monitoring. The choice between the preventive care advised and the preventive and operative care advised will depend on this decision, and the clinical end point
criteria during the excavating procedure is unfortunately still subjective. Therefore we can divide our preventive and minimalist therapies into 2 groups: the first
(Minimally Invasive Treatment 1 or MIT1) for treating enamel and enamel-dentine lesions without any preparation, provided that there is no surface cavitation. The
second group (Minimally Invasive Treatment 2 or MIT2) is for treating early enamel-dentine lesions with surface cavitation and the main clinical challenge is to be able
to see this first demineralization process as earliest as possible. Fluorescence dental devices e.g Soprolife, Diagnodent, Vistaproof could certainly enhanced the
precision of our diagnosis depend of relevant sensitivity and specificity of the fluorescence devices and with no doubt increased ours knowledge during all the
treatment steps due to the fluorescence signals and the pictures magnification. The purpose of this lecture is to discus about the link between caries classification,
clinical operative treatments decision and fluorescence-based methods.
151
A
AASS, A. 287
ABDALLA, A. 364
ABDEL KARIM, U. M. 59
ABED, Y. 416
ABO, T. 469
ABOU-RABII, I. 465
ABOUT, I. 3
BRM, E. 532
CS, P. 84
AGICS, A. 268
AGUSTN PANADERO, R. 118, 292, 299
AIACHE, J. M. 465
AKCALI, A. 184
AKIN, M. 145, 229, 322
AKINCI, O. 313
AKIYAMA, H. 130
AKIYAMA, S. 420
AKMAN, M. 64
AKMAN, S. 71
AKSAKALLI, S. 229
AL JABBARI, Y. 379
AL SHERBINEY, H. 222
AL-NAJJAR, H. A. A. A. 274
ALADZIC, D. 507
ALARCON, J. A. 30, 31
ALB, C. I. 168
ALBALADEJO, A. 259
ALBANIDOU-FARMAKI, E. 488
ALBERNAZ NEVES, J. 11
ALHADAINY, H. A. 59
ALI, O. 516
ALI, R. W. 280
ALMEIDA, A. 75
ALNIACIK, G. 66
ALP, C. K. 367
ALPTEKIN, T. 226, 227
ALTDORFER, K. 92, 458
ALTENBURGER, M. 489
ALTINKAYA, O. 533
AMARIEI, C. 109
AMATO, M. 63, 410
AMBROSIO, L. 262
AMEMORI, M. 78
AMENDT, B. 527
AMER, M. 40
AMETRANO, G. 63, 262
AMOUZANDEH, R. 496
AN, C. H. 483
AN, P. H. 483
ANAGNOSTOU, F. 263, 324
ANDO, K. 94, 95
ANDONOV, B. 79
ANDREADIS, D. 354, 488
ANDREAS, W. 326
ANGERAME, D. 375, 380, 381
ANGILERI, F. 12
ANNUNZIATA, M. 338
ANOGIANNAKIS, G. 265
ANTAL, M. 22, 88, 103, 190, 406, 422, 424, 471
ANTAL, P. 530
ANTEBY, I. 32
APOSTOLSKA, S. 61
ARAI, C. 277
ARDELEAN, L. C. 510
ARENDT, C. 109
ARHUN, N. 377
ARIJI, E. 94, 95, 96, 490
ARIJI, Y. 94, 95, 96, 490
RNADTTIR, I. B. 352, 356
AROCA, S. 336, 547
ARSLAN, I. 224
ARWEILER, N. B. 268
ASLAN, B. 539
ASMUSSEN, K. H. 138
STVALDSDTTIR, . 127
ATANACKOVIC, T. M. 62
ATILLA, G. 538
ATMEH, A. 1
ATTIN, T. 44, 295, 309, 325, 362
AURER, A. 290
AXE, A. 468
AYAR, M. K. 367
AYHAN ALKAN, E. 230, 236
AYKENT, F. 71, 226, 227, 228
AZAVEDO, C. 7
AZUL, A. C. 11, 213, 214, 225
B
BACHANEK, T. 153
BCSKAI, T. 114
BCSKAY, I. 261
BADEA, V. 109
BGE, T. 393, 544
BGYI, K. 463
BAI, K. B. 104, 286
BAKA, Z. M. 148, 149
BAK, J. 46, 261
BAKOPOULOU, A. 369
BALASKO, M. 279
BALDEA, B. 190
BAN, A. 279
BN, . 535
BANITO, E. 136
BNCZY, J. 112
BNYSZ, T. 503
BAR NESS GREENSTEIN, R. 99
BARACCO, B. 194
BARLA-SZAB, P. 316
BARRIESHI-NUSAIR, K. M. 274
BARROSO, H. 136, 140
BARTOLOM, J. F. 512
BARTSCH, C. 319
BASCIFTCI, F. A. 37, 147, 229, 322
BASSO, M. 163
BATBAYAR, B. 92
BAUDOUIN, C. 199
BAUM, M. 106, 107
BAUMANN, P. 84
BAYGIN, O. 224
BAYRAKTAR, G. 417
BAYRAM, S. 37
BECERIK, S. 538
BECK, A. 76, 77, 111
BECKER, J. 421
BECKER, K. 325
BECKER, T. 133
BEER, R. 60
BEHR, M. 297, 300, 301
BEHREND, D. 302, 319
BEIKLER, T. 17, 525
BEKE, D. 6
BEKES, K. 216, 217, 445
BELLI, S. 64
BEN-BASSAT, Y. 32
BENKE, B. 249
BENNASAR, B. 65
BENYO, B. 178
BERARD, A. 493
BERARD, A. 492
BERCY, P. 536
BERDAL, A. 323
BERGMAN, L. 290
BERGMANN, N. 17, 48, 525
BERISALIC, A. 50
BERKEI, G. 269, 501
BERMEJO, J. L. 414
BERNARDO, M. A. 405
BERTA, G. 327
BERZE, I. 42
BESINIS, A. 312
BEUER, F. 245, 304, 514
BICAKCI, N. 184
BICAKCI, T. 184
BIEDERMANN, A. 182
BIOANIN, V. 357
BIRINYI, P. 503
BIRLER YAGLI, D. 417
BIRO, S. 264
BR, T. 52
BISDAS, T. 330
BISIRICI, G. 145
BISTEY, T. 150
BITTER, K. 250
BIZHANG, M. 495
BLANC, V. 541
BLASE, D. 536
BLATZ, M. B. 440
BLAZSEK, I. 151
BLAZSEK, J. 151
BLEICHER, F. 199
BOCK, A. 221
BOCK, T. 439
BODA, R. 255
BDDI, K. 316, 391
BOLAY, C. 523
BOLAY, S. 126
BOLIS, C. 418
BOLOS, O. C. 412
BOLSTAD, A. I. 280
BONDOR, C. 240
BONETTI, S. 33, 35
BONNET, J. M. 320
BORBLY, J. 23, 173, 261
BORBLY, Z. 151, 392
BORI, E. 390, 392
BORS, A. 38
BORSICZKY, B. 394
BORSOS, G. 8
BORTUN, C. M. 412
BOTOS, A. 41
BOUTONNET, M. 492
BOZKURT, S. 539
BRADSHAW, D. J. 443, 466
BRAJKOVI, D. O. 357
BRATU, D. 190
BRAUN, P. 307
BRECX, M. 332, 536
BREDE, O. 553
BRESCHI, L. 122, 250
BRIN, I. 32
BRITO, J. 214, 225
BRKIC, H. 29
BRKOVI, B. M. 357
BRONCKAERS, A. 200, 201
BRONKHORST, E. 196
BROOK, H. 443
BROT, A. 431
BROUKAL, Z. 82
BUCHNER, A. 133
BUDAI, J. 46
BUKOVINSZKI, K. 23
BULBUL, M. 121, 518
BUOSCIOLO, A. 338
BURAL, C. 417
BURNETT, G. R. 443
BURTSCHER, P. 431
BUSCH, A. 319
C
CABRERA, E. 194
CALENIC, B. P. 146
CALIAPEROUMAL, G. 324
CAO, H. 527
CAPPERUCCI, A. 308
CAPTIER, G. 26, 27
CARDOSO, M. V. 342, 363
CARRABBA, M. 72, 308
152
AUTHOR/CO-AUTHOR INDEX
CARROUEL, F. 199
CARVALHO, J. 477
CARVALHO, R. C. R. 363
CATIC, A. 67
CATTARUZZA, M. 381
CAVACAS, M. A. 321
CAVALEIRO, I. 472
CEBALLOS, L. 47, 194, 378
CEBE, F. 313
CEHRELI, S. B. 377
ELEBI, A. 68
CELIK, C. 377
ELIK, I. 283
CENEDESE, P. 7, 415
CENTENO, I. 75
CERNESCU, A. 412
CETINER, D. 278
CETINER, F. 428
CETINER, H. 428
CHABADEL, O. 26, 27
CHAIPHOTCHANAPHONG, N. 451
CHAKAR, C. 263
CHALAS, R. 153
CHANTARANGSU, S. 483
CHAPPLE, I. L. 186
CHASS, G. 158
CHATZIVASILEIOU, K. 272
CHAUDHARI, A. 342
CHEN, C. 116
CHEN, H. M. 482
CHENG, C. Y. 444
CHENG, S. J. 482
CHIANG, C. P. 482
CHIRIAC, H. 223
CHOPIN, M. P. 492
CHOUSEIN, C. 145, 148, 149
CHRISTIANE, G. 326
CIKA, E. 449
CIGLAR, I. 246
CIMIC, S. 67
CLAESSON, R. 446
CLOITRE, T. 551
COHEN, E. 32
COIMBRA, P. 55
COLAK, M. 377
COLAT-PARROS, J. 411
COLLART DUTILLEUL, P. Y. 54
COLON, P. 4, 315
COLOSI, H. 172
CORN, S. 513
CORREIA, I. 55
COUTINHO, P. 75
CSEH, A. 478
CSEH, G. 394
CSIZMADIA, I. 158
CUISINIER, F. 65, 513, 552
CUISINIER, F. J. 5, 43, 54, 365, 551
CUNIN, F. 54
CURA, M. 378
CZAJKA-JAKUBOWSKA, A. 449
CZARNECKA, B. 191
D
D'ANT, V. 262, 408, 410
D'ARCANGELO, C. 12
DADAMIO, J. 491, 498
DAGHER, S. 232
DAGLIA, M. 396
DALESSANDRI, D. 34, 35, 284
DALESSANDRI, M. 284
DANILA, I. 223
DARD, M. 333
DARLING, M. 483
DAROCZI, L. 6, 264
DASTMALCHI, N. 128
DATEOKA, S. 257, 258
DAUNIS, D. 65
DAVANIAN MOHAGHEGH, H. 544
DAVIDEAU, J. L. 181, 323, 537
DE ANGELIS, F. 12
DE ARRIBA, L. 425
DE BIASI, M. 375, 380, 381
DE LA MACORRA, J. C. 425
DE LUNA-BERTOS, E. 102
DE MUNCK, J. 120, 123, 125, 160, 161, 189, 197, 162, 215,
318, 359, 360, 521
DE PERALTA, T. 48
DE SANTIS, R. 262
DE VERDIER, B. 127
DE VICENTE, J. C. 425
DEK, . 114
DECKEYSER, C. 491, 498
DECLERCK, D. 399
DEDOVIC-TANIC, N. 169
DEL SIENA, F. 308
DELIGIANNIDIS, A. 488
DEMETER, T. 171
DEMIR, A. 229, 313
DEMIR, N. 373
DEMIREL, K. 183
DEMOLI, N. 18, 24
DEPERALTA, T. 312
DERELY, L. 365
DRI, K. 45
DEVILLE DE PERIERE, D. 110
DHANUTHAI, K. 483
DI CAPRIO, M. P. 410
DI CARLO, T. 481
DI LIETO, M. 481
DAZ-RODRGUEZ, L. 102
DIDILESCU, A. C. 56, 146, 270
DIJKENVAN, J. 446
DILBER, E. 156
DIMITROVA-NAKOV, S. 202
DIMKOV, A. 61
DINER, M. 539
DIONYSOPOULOS, D. 419
DISCHINGER, L. 489
DITTMANN, R. 306, 307
DJALALI, A. 73
DOBO-NAGY, C. 53, 113, 151, 158, 177, 178, 506
DOBROSI, N. 52
DOBSA, J. 327
DODIC, S. 374
DOGARU, C. 459
DOI, K. 100, 494
DOMBI, C. 286
DRI, F. 268, 548
DOWERK, T. 300
DOZIC, A. 50, 441
DRAGOS, O. 223
DRATSIOS, S. 265
DROBAC, M. R. 62
DUBOT, P. 7, 415
DUDEA, D. 41, 168, 172
DUGGAL, M. S. 311
DUMITRESCU, A. L. 276, 459, 464
DUNAVRI, E. 249
DUPAS, P. H. 480
DUPUIS, V. 492, 493
DURAND, J. C. 365
DUTA, C. 459
DUYCK, J. A. 342
E
EBERHARD, J. 330, 475
EBERHARD, L. 39
ECE, H. S. 148, 149
EDELHOFF, D. 157, 245, 304
EDEN, E. 461
EGEA, J. C. 110
EHLERS, V. 159
EICK, S. 141, 275
EIFFLER, C. 293
EISEMANN, M. 353
EISENBRAND, G. 106, 107
EKEN, R. 236
EL-DEEB, H. A. 222
EL-OSTA, N. 232
ELDENIZ, A. U. 135, 543
ELIADES, G. 154, 366, 379, 516, 519, 520
ELIASSON, S. T. 195, 233
ELKAM, R. 181
ELSHAHAWY, W. 340
ELVERDIN, J. C. 40, 266
EMERICH, M. 131
EMINGIL, G. 538
ENGELS, J. 514
ENGGIST, L. 237, 238
EPIVATIANOS, A. 354, 488
ERDELT, K. 514
ERDEMIR, U. 19, 247
ERDOGAN, C. 539
ERDHELYI, B. 176
ERES, G. 282
ERIKSEN, H. 353
ERN, C. 203, 234
ERNST, C. P. 159
ESKITASCIOGLU, G. 64, 230, 236
ESPIG, C. 60
EYJLFSSON, H. I. 486
F
FABER, F. J. 73, 496
FBIN, G. 499
FBIN, T. K. 76, 77, 111, 389
FABRE, J. E. 537
FAGES, M. 65, 513
FAGGION, C. 175
FARAG, I. 83, 456
FARGES, J. C. 199
FARKAS, V. 463
FARMAKIS, K. 488
FARR, J. C. 221
FARRONATO, G. 529
FAUR, N. 412
FAUS, I. 219
FEHR, E. 92, 458
FEILZER, A. 524
FEILZER, A. J. 116, 198
FEJRDY, P. 76, 77, 111, 158, 173
FLIX, S. 472, 477, 480
FELSZEGHY, S. 152
FENTOGLU, . 288
FERNANDEZ-ESTEVAN, L. 413
FERNANDEZ-SOLARI, J. 40, 266
FERRACANE, J. L. 207
FERRARI, M. 72, 243, 308, 372
FERREIRA, P. 55
FERREIROA, A. 512
FETZER, D. 106
FIDAN, A. 253
FIDANCIOGLU, A. 37
FIGUEIREDO, M. H. 55
FIGUERO, E. 541
FINGER, W. J. 346
FIRAT, E. 502
FLOREA, A. 41
FLOREZ, S. 527
FODOR, A. 529
FLDES, A. 392
FOLWACZNY, M. 203
FONS FONT, A. 118, 292, 299
FORGO, G. 429
FORMISANO, A. 63
FORSTER, A. 22, 88, 406, 423, 424
FRANK, D. 394
FRATER, M. 103, 471
FREDERICO, R. 491, 498
FRENTZEN, M. 317, 376
FRIEDMAN, M. 32
FRIEDMANN, A. 333
FROMENTIN, O. 415
FU, J. 361
FUENTES, M. V. 378
FUJII, T. 256
FUJIWARA, Y. 57
153
FLP-PAPP, M. 151
FURTOS, G. 190
FUSEJIMA, F. 420
FZESI, Z. 170
G
GALANIS, C. 251
GALIC, E. 29
GALIC, I. 29
GALL, J. 23
GALLYAS, F. 132
GALOSI, T. 245
GALRO, J. 140
GANSS, B. 166
GARAGIOLA, U. 529
GARCA-MARTNEZ, O. 102
GARRIDO, M. A. 47
GAZZANI, G. 396
GEDRANGE, T. 8
GEEBELEN, B. 521
GEHRT, M. A. 155
GEIS-GERSTORFER, J. 235, 303
GELENCSR, G. 132, 535
GEORGSSON, P. 545
GERA, I. 208, 268, 286, 329, 334, 336, 337
GERGELY, C. 5, 54, 551
GERLACH, R. 445
GERNHARDT, C. R. 216, 217, 445
GERO, D. 351
GEURTSEN, W. 123, 369, 407
GHEORGHIU, C. 240
GHIBAN, A. 412
GHIDN, . 470
GIANASMIDIS, A. 431
GIANNAKOPOULOS, N. N. 39, 546
GIETL, H. 302
GILLET, D. 492, 493
GIORDANO, M. 338
GIRLDEZ, I. 47, 194
GJORGIEVSKA, E. S. 61
GLSER, C. 335
GLORIA, A. 262
GBEL, A. 442
GODDERIS, L. 521
GOGOS, C. 244
GOLDBERG, M. 202
GOLDBERG, M. B. 2
GOLUBOVIC, V. 421
GMEZ DE DIEGO, R. 259
GONZLEZ LPEZ, S. 241
GOODACRE, C. J. 129
GORACCI, C. 72, 243
GTAI, L. 76, 77, 173
GRABENBAUER, B. 431
GRANELL RUZ, M. 118, 292, 299
GRANELL, M. 291
GREABU, M. 146
GREENMAN, J. 144, 349, 460
GRISLAIN, L. 508
GRITSCH, K. 320
GROBLER, S. R. 231
GROSGOGEAT, B. 315, 320, 343
GROSSGARTEN, M. 317, 376
GROTEN, M. 235, 298
GRUBER, R. 9
GUDBJRNSSON, B. 486
GURIN-DEREMAUX, L. 444
GUGGENBERGER, R. 218, 430
GUIDA, A. 338
GUIDA, L. 338
GLCAN, F. 461
GUNESER, M. B. 135
GNHAN, . 288
GURGAN, S. 502
GRSEL, M. 283
GURSOY, M. 289
GURSOY, U. K. 289, 476
GUSTAFSSON, A. 545
GTH, J. F. 157, 304
GUZES, M. 147
GYORGYEY, A. 406, 423
GYURKOVICS, M. 137, 269, 501
H
HADADI, . 530
HADIMLI, H. H. 135
HAENEL, T. 15
HAFFNER, M. 326
HAFIZ CURY, A. 372
HAHN, P. 119
HAHNER, S. 48
HAJ-YAHIA, H. 416
HAJDU, E. 103, 471
HALLGAT, J. 271
HALUK BARIS, K. 226
HAMADA, M. 254, 256
HAMURA, A. 130
HAN, A. 444
HAN, D. H. 267
HANADA, N. 277, 469
HANDEL, G. 297, 300, 301, 515
HANDY, R. 312
HANGANU, S. C. 91
HANSEN, F. 287
HANYECZ, I. 46
HARA, S. 130
HARASZTHY, G. 429
HARASZTHY, V. I. 429, 473, 474
HARICHANE, Y. 202
HASIC-BRANKOVIC, L. 441
HATORI, K. 342
HATTORI, H. 94, 95, 96
HAUSINGER, K. 107
HAUSNEROV, B. 15, 317, 376
HAVERICH, A. 330
HAYAKAWA, S. 124
HECHT, R. 430
HEGEDS, C. 6, 23, 46, 150, 152, 248, 261, 264, 506
HEGEWALD, A. 421
HEGYESI, O. 392
HEIDE, S. 326
HEIDUSCHKA, R. 106, 107
HEIKO, S. 326
HELGADTTIR, H. 352
HELLMANN, D. 39, 546
HELLWIG, E. 328, 370, 522
HELVATJOGLU-ANTONIADES, M. 419, 436
HENTER, L. A. 279
HERCZEGH, A. 470
HERMANN, P. 76, 77, 111, 173, 530, 532
HERNNDEZ, G. 425
HERRERA, D. 541
HERRMANN, J. M. 331, 540
HERTWIG, J. 335
HEUER, W. 330, 475
HEVR, H. 92
HEWETT, K. 144, 460
HICKEL, R. 14, 16, 126, 203, 234, 543
HILKENS, P. 201
HILLER, K. A. 51, 523
HIRAIWA, Y. 490
HIRANO, K. 97
HIRATA, A. 202
HIRT, T. 431, 439
HIRTZ, C. 110
HMAIDOUCH, R. 517
HOET, P. 521
HOFFMANN, M. 514
HOHMANN, C. 511
HOLBROOK, W. P. 127, 356, 486
HOLLS, E. 52
HOLM, L. M. 138
HOLST, S. 402
HONDA, A. 57
HONG, N. T. 483
HONTVRI, D. 337, 530
HOPCRAFT, M. 83, 456
HOPP, B. 423
HORVTH, A. 329
HORVTH, I. 113
HOSHIJIMA, H. 100, 494
HOSHIKA, S. 189, 215, 359, 360
HOTTON, D. 323
HUCK, O. 181, 323, 537
HUETTIG, F. 235, 298
HULLM, G. 530
HUSZAR, T. 268
HUYSMANS, M. C. 196
I
IENNY, P. 513
IINUMA, M. 499
IIZUKA, J. 447
IKEDA, S. 341
IKEDA, T. 361
ILERI, Z. 147, 148, 149
ILIE, N. 14, 126
ILLES, D. 36
IMAI, S. 469
IMFELD, T. 444
INAMOTO, K. 94, 95, 96
INAN, . 66, 117
INDO, H. 504
INGIMUNDARDTTIR, S. 352
INOKOSHI, M. 120, 360
INOUE, H. 257, 258
IORDANIDIS, F. 354
IORDANIDIS, S. 354
IRIBOZ, E. 440
IRIMIE, A. 168, 172
ISHII, K. 25
ISHIKAWA, M. 277
ISHIKAWA, Y. 277
ISHRAQ, S. 528
ISOGAI, E. 273
ISOGAI, H. 273
ISSA, S. 7
ITO, Y. 94, 95, 96
IWASHITA, Y. 504
J
JACKSON-BOETERS, L. 483
JACOBSEN, S. 138
JACQUOT, B. 365
JAEGER, A. 51
JAFARZADEH, H. 128
JAHNS, M. 305
JAKUPOVIC, S. 50
JAMRZ-WILKOSKA, L. 58
JANDA, R. 17, 525
JANDT, K. 542
JANKOVIC, B. 246
JANKOVIC, S. 29
JSZ, M. 42, 112
JAUERNIG, C. 514
JEGES, S. 249, 358, 500
JENEI, . 52, 150, 264, 463
JENTSCH, H. F. R. 56, 270, 275
JEZNACH, M. K. 467
JIA, L. 362
JOBBGY-, G. 337
JOBBGY-OVARI, G. 38, 530
JOHANNSEN, A. 310
JOHANNSEN, G. 310
JOHANSSON, E. 446
JOHNSON, A. 515
JONES, L. A. 467
JONGSMA, L. A. 198
JNSDTTIR, H. K. 486
JNSSON, J. 545
JONSSON, S. 356
JORDAN, R. A. 453, 454
JORDANA, F. 411
JOSHI, R. 341
JUHSZ, A. 506
JUKIC KRMEK, S. 87
154
JULOSKI, J. 243
JUNCKER, A. K. E. 479
JURCZYK, K. 449
K
KHIDAI, L. 104, 286
KAN, M. 173
KACHRIMANIS, N. 21
KDR, L. 462
KDR-NAGY, J. 294
KAFFE, I. 133
KAFTANDZIEVA, A. 61
KAKUDO, K. 254, 256, 257, 258
KAKUTA, E. 277
KALAYCI, A. 533
KLL, K. 111, 151
KAMEYAMA, A. 120, 215, 318, 359, 360
KAMMANN, A. 431
KAMPF, G. 159
KANEKO, A. 469
KAPPELMAYER, J. 455
KAPRIO, J. 93
KARA, H. B. 156, 227, 228
KARADUMAN, U. 283
KARI, K. 139, 143
KARLSSON, L. 446
KARMOS, G. 53
KROLYHZY, K. 462
KARPATI, K. 108
KASAI, K. 25
KASAJ, A. 56, 270
KASHYAP, K. 440
KASSEM, M. 30, 31
KASUBA, V. 409
KATONA, B. 264
KATS, A. 393, 545
KATSARES, V. 488
KATSUMATA, A. 490
KAWABATA, Y. 504
KAWANO, K. 504
KECSKEMTI, G. 423
KEGLEVICH, T. 336
KELENTEY, B. 105, 114
KELLER, J. F. 199
KELLERMANN, O. 202
KELLERMAYER, M. 113
KENDE, D. 170, 249, 358
KEREKES-MTH, B. 38, 530
KEREMI, B. 180, 351
KESKIN, S. 230, 236
KESKINOVA, D. 239
KETTUNEN, P. 28
KEUL, C. 304
KEYER, G. 326
KIM, J. B. 267
KINDLER, G. 305
KINNUNEN, T. 78
KIRCHNER, H. G. 203
KIRZIOGLU, F. Y. 288
KIS, P. 269, 501
KISE, Y. 490
KISLIG K. 350
KISS, C. 134, 478
KITKUMTHORN, N. 485
KLARIC, E. 409
KLEIN, D. 245
KLEVERLAAN, C. 441
KLEVERLAAN, C. J. 116, 198, 524
KNUUTTILA, M. L. E. 90
KOBASLIJA, S. 441
KOBAYASHI-SAKAMOTO, M. 273
KO, O. 69
KOCAK, A. 288
KOCSIS, B. 394
KOCZOROWSKA, A. 449
KOH, T. 98
KHRER, D. 453
KOIDIS, P. 251, 265, 369
KOKENYESI, S. 6
KOKENYESI, V. 6
KOLAROVSZKI, B. 394
KOLBECK, C. 297, 300, 301, 515
KOLDSLAND, O. C. 287
KOLINIOTOU-KOUMPIA, E. 368, 419
KONDO, M. 256
KONDO, Y. 487
KNIG, A. 522
KNNEN, E. 289, 476
KONTOS, L. 303
KOPJAR, N. 409
KOPOSOV, R. 353
KOPOSOVA, N. 353
KOPP, S. 509
KORHONEN, T. 78
KORKMAZ, F. M. 224
KOROM, C. 269, 501
KORTEN, M. 305
KOSITPANTAVONG, C. 432
KOTSANOS, N. 419
KOULAOUZIDOU, E. 244, 368, 436
KOUNTOURAS, K. 436
KOUROS, P. 368
KOUTSONIKOLAS, D. 265
KOVCS, G. L. 394
KOVCS, K. J. 387
KOVCS, V. 505
KRAJCZR, K. 249, 358, 500
KRAMER, P. R. 340
KREIKEMEYER, B. 182
KRIEBEL, K. 182
KRIFKA, S. 523
KRISDAPONG, S. 451
KRGER, B. 546
KRUPISKI, J. 58
KUCHLER, U. 9
KUCZUMOW, A. 153
KHN, C. 330
KUHNT, T. 445
KUKOVECZ, A. 406
KUNERT-KEIL, C. 8
KUNZELMANN, K. H. 16
KUPER, N. 196
KURATA, S. 487
KURATANI, N. 100, 494
KUSHIDA, T. 101
KVINNSLAND, I. H. 28
KYPRAIOU, V. 154
L
LABAIG RUEDA, C. 118, 299
LABAIG, C. 291, 427
LABELLA, R. 187
LAGOS, E. 291
LAJK, E. 286
LAJNERT, V. 296
LAM-UBOL, A. 483
LAMBRECHTS, P. 318
LAMBRICHTS, I. 200, 201
LAMPE, I. 152
LANG, H. 182, 272
LNG, O. 104
LAROCHE, N. 320
LARROUTURE, D. 508
LASCU, V. 276, 464
LASSERRE, J. 332, 536
LEHMANN, F. 414
LEHMANN, S. 110
LEMAGNEN, G. 508
LEMPEL, E. 249, 316, 358, 391
LENARDUZZI, A. L. 40
LENCOVA, E. 82
LENDENMANN, U. 418
LENGUAS, L. 30, 31
LEN, R. 541
LESAFFRE, E. 400
LETSCH, C. 297
LEVALLOIS, B. 43
LEVALLOIS, B. N. 551
LEVINE, M. 180
LEYHAUSEN, G. 369, 407
LI, X. 527
LILJEBORG, A. 310
LIMPERT, T. 275
LIN, H. P. 482
LINGSTRM, P. 395
LIPPERT, J. P. 331, 540
LIPPMANN, A. L. 76, 77
LISCHEWSKI, S. 335
LISZKAY, G. 505
LITZENBURGER, A. 234
LIVNY, A. 416
LLAMA-PALACIOS, M. A. 541
LOEFFLER, S. 51
LOGHI, S. 375
LOHINAI, Z. 137, 180, 269, 351, 501
LOHINAI, Z. M. 286, 470
LOLL, H. 218
LOOS, B. G. 209
LOPES BANDEIRA, L. 136
LOPES, M. A. 213
LPEZ DEL MORAL, J. 259
LPEZ-PINTOR, R. M. 425
LPEZ-VALVERDE, A. 259
LOUWAKUL, P. 497
LOVRIC, Z. 29
LUCACIU, A. 333, 453
LUDERER, F. 475
LUDSTECK, M. 430
LHRS, A. K. 123
LUKCS, E. 327
LUPI, A. 408
LUSSI, A. 131
LUTZ, R. 534
LUUKKO, K. 28
LUUKKONEN, N. 476
LUVIZUTO, E. R. 9
LUX, C. A. 272
LYNCH, E. 465
M
MASZ, G. 535
MACHINO, M. 98
MACIOCE, V. 444
MADLNA, M. 83, 173, 456, 530
MAEDA, N. 469
MAFTEI, I. 223
MAGNSDTTIR, J. 352
MAGYAR, J. 503
MAIER, M. C. 137
MAJEED, A. 231
MAJIMA, H. 504
MAJOROS, L. 105
MAJSTOROVIC, M. 115
MAKINO, T. 101
MAKOU, M. 516
MALINOWSKI, M. 311
MANCHOROVA-VELEVA, N. A. 239
MANDA, M. 251, 265
MANDELLI, G. 33, 34, 35
MANG, T. 429
MANHART, J. 234
MANOJLOVIC, D. 314
MANOLESCU, B. 459
MANOLOVA, M. 79
MANSO, A. G. 74, 75, 405
MANTA, P. 265
MARADA, G. 84, 170, 500
MARGERIT, J. 365, 513
MARICIC, S. 296
MARN-CUENDA, M. J. 541
MRK, L. 535
MARKOPOULOS, A. 354, 488
MARKOVIC, L. 60
MARQUIS, R. 466
MARRONE, A. 332
MARSH, P. D. 185
MARTENS, W. 200, 201
155
MRTHA, K. 38
MARTIN, C. 30, 31
MARTIN, M. 5, 551
MARTNEZ-RUS, F. 512
MARTINS DOS SANTOS, J. 321
MARTINS, F. 75
MARTINS, J. 214
MRTON, I. 105, 134, 463, 455, 478, 503, 506
MRTON, I. J. 255
MRTON, K. 171
MRTON, S. 83, 456
MARTONOSI, M. 530
MARTOS, R. 455
MASTORAS, K. 244
MATESZ, K. 114
MTH, D. 113
MATIJEVIC, J. 87
MATOSEVIC, D. 18
MATSUMOTO, N. 100, 494
MATTILA, P. T. 90
MAURCIO, P. D. 241, 477
MAXWELL, A. 468
MAYR, H. 305
MAZZAGLIA, G. 102
MCDONALD, F. 528
MEDIC, V. 374
MEHLICH, M. 119
MEHULI, K. 68, 290
MEIER, F. 439
MELA VITALONE, L. 12
MERT EREN, M. 19
MESAROS, A. 168, 172
MESMER, C. 235, 298
MESQUITA, M. F. 405
MEURMAN, J. 139, 142, 143
MEURMAN, J. H. 281
MEYLE, J. 331, 540
MEZ, G. 104, 286
MICHIE, S. 78
MICIC, A. 250
MIHATOVIC, I. 421
MIHU, C. 41
MIK, S. 457
MIKUNI-TAKAGAKI, Y. 447
MIKUSI, R. 177
MILARDOVI, S. 68, 290
MILETIC, V. 314
MILHEIRO, A. 524
MILI, M. S. 357
MILOSEVIC, M. 314
MILOSEVIC, S. 246
MILUTINOVIC-NIKOLIC, A. 374
MINAGI, S. 124
MINAKUCHI, S. 120
MINE, A. 125, 161, 162
MISETA, A. 394
MITROVIC, N. 314
MIYABE-NISHIWAKI, T. 469
MIYAKE, K. 16, 487
MIYANOHARA, M. 469
MIYASHITA, W. 130
MIZUNO, K. 81
MOBARAK, E. 222, 242
MODER, T. 393
MODIS, K. 351
MOE, K. 28
MOEGINGER, B. 15, 317, 376
MOGYORSSY, R. 114
MOHCSI, . 507
MOHN, C. E. 266
MOLDOVAN, M. 41
MOLNR, B. 334, 336, 337
MOMOI, Y. 469
MONACO, E. 429
MONTEIRO, I. 480
MONTERO, J. 259
MONTICELLI, F. 372
MONTSK, G. 394
MOOLA, M. H. 231
MRA, M. 507
MOREAU, K. 343
MORETTO, S. G. 363
MORI, T. 94, 95
MORITA, I. 81, 94, 95, 96, 450
MOULIS, E. 26, 27
MOUROUZIS, P. 436
MOUSSA, M. A. 20
MRAKUZIC, M. 24
MSIKA, P. 199
MUELLER, W. D. 13, 517, 519
MUHTAROGULLARI, M. 66
MUKAI, Y. 447
MULIC, A. 85, 86
MLLER, H. P. 274
MLLER, U. 542
MLLER, W. D. 21
MURAKAMI, Y. 98
MURARIU, A. 91
MUROI, Y. 254, 256
MURTOMAA, H. 78
MUSTAFA, M. 280
MUTIRANGURA, A. 484, 485
MYANGAR, N. 452, 467
N
NAAMAN, N. 263
NAERT, I. 342, 371
NAGAOKA, N. 124
NAGY, . 170, 391, 394, 530
NAGY, B. 279
NAGY, D. 530
NAGY, E. 424
NAGY, G. 83, 337, 456
NAGY, I. P. 150
NAGY, K. 22, 80, 88, 103, 108, 190, 260, 294, 401, 406,
422, 423, 424, 429, 471, 507, 526
NAGY, L. 463
NAGY, P. 158
NAGY, T. 394
NAKAGAKI, H. 81, 94, 95, 96, 450
NAKAGAWA, M. 340
NAKAJIMA, M. 257, 258
NAKAMURA, F. 450
NAKAMURA, H. 94, 95, 96
NAKAMURA, Y. 277
NAKAOKI, Y. 361
NAKATA, K. 94, 95, 96
NALBANTSOY, A. 184
NNSI, P. 503
NASCIMENTO, T. 477
NATHANSON, D. 129
NAUMANN, M. 511
NDOBO-EPOY, P. 493
NEGOVETIC MANDIC, V. 246
NEGOVETIC VRANIC, D. 115
NEMES, B. 260
NEMES, J. A. 255
NEMETH, O. 80
NEMETH, Z. F. 279
NEUHAUS, K. W. 131
NEWBY, C. S. 466
NICA, L. 190
NICA, L. M. 56, 270
NICHOLSON, J. 61, 158
NIEDERMEIER, W. 496
NIHEI, T. 16, 487
NIKITA, K. 351
NIKLAS, A. 51
NISKANEN, M. C. 90
NOACK, M. J. 205, 206
NOCCA, G. 408
NODA, K. 277
NOMURA, Y. 277, 469
NONHOFF, J. 534
NORONHA, J. P. 405
NOVK, P. 422, 507
NOWAK, J. 153
NOZAKI, T. 49
NTASI, A. 519
NUCA, A. M. 109
NUCA, C. 109
NUNES, A. L. 213
O
O'NEILL, P. 129
OBERNA, F. 532
OBRADOVIC-DJURICIC, K. 374
OFFENMLLER, K. 113
OGAWA, T. 469
OGODESCU, A. 56
OHASHI, K. 16, 487
OHKUMA, M. 469
OHLMANN, B. 293
OHMANN, C. 454
OHNISHI, Y. 257, 258
OHURA, K. 49
OKAMOTO, M. 469
OKANO, T. 341
OKUKA, S. 234
OKUMURA, K. 273
OLASZ, L. 391, 535
OLIVA, A. 338
OLIVEIRA, M. J. 321
ONISEI, D. 56
OOM, M. 472
OOTA, K. 256
OPDAM, N. J. M. 196
OPDENAKKER, G. 123
ORUCOGLU, H. 373
OSAKA, A. 124
OSSOLA, C. A. 266
OSZK, A. 423
OTTE, P. 454
OTTL, P. 319
OVECOGLU, H. 440
OZCAKA, O. 184
ZAKA, . 538
OZCAN, M. 70, 437, 438
OZCOPUR, B. 64, 230, 236
ZDEM, M. 288
ZDEMIR, B. 539
OZEL, S. 19, 247
OZER, F. 440
OZTURK, A. N. 69, 121, 156, 373
OZTURK, B. 228, 373
OZTURK, E. 126
OZTURK, O. 70
OZYILMAZ, O. Y. 226, 227
ZYILMAZ, . Y. 71
P
PAGANELLI, C. 33, 34, 35
PAJUKANTA, R. 289
PAK-TUNC, E. 428
PALAGHIAS, G. 220
PALANIAPPAN, S. 318
PALLESEN, U. 193
PLLINGER, . 286
PALMA, P. 55
PAN, F. 361
PANAYOTOV, I. 79, 551
PANAYOTOV, I. V. 5, 43
PANDURIC, V. 24
PAPADOGIANNIS, D. 220
PAPADOGIANNIS, Y. 220
PAPADOPOULOS, C. 265
PAPADOPOULOS, T. 516
PAPETTI, A. 396
PAPP, T. 152
PAR, M. 409
PARAGH, G. 455
PARAPANISIOU, E. 488
PARASKEVOPOULOS, K. 265
PARAVINA, R. D. 129, 345
PSKA, C. 337, 530
PAUCKOVA, E. 442
PAULIK, E. 80
156
PAVICIC, D. K. 296
PEDERSEN LYNGE, A. M. 138
PEDERSEN, A. M. L. 479
PELEKANOS, S. 154
PELSCZI, I. 423
PERCZEL-KOVCH, K. 111, 151
PERDIGAO, J. 194, 321
PERINIC, M. 296
PERRIN, P. 131
PERI, S. 68
PESCHKE, A. 237, 238
PETERCSAK, A. 248
PETERS, M. C. 204, 449
PETITE, H. 263, 324
PETROVIC, L. M. 62
PETROVIC, N. 169
PTURSSON, E. 486
PEUMANS, M. 162, 363
PEUMANS, M. 161, 197
PEYRETOUT, J. 343
PFISTER, W. 275
PHATTATARATIP, E. 483
PICHLMAIER, M. 330
PIFFK, J. 294, 422, 531
PIKHART, H. 82
PINKE, I. 80, 526
PIZZEY, R. L. 466
POITEVIN, A. 125, 161, 162, 197, 318
POLIARD, A. 202
POLIDO, M. 11, 213, 214, 225
POLITIS, C. 200, 201
POLYDOROU, O. 370, 522
POULOPOULOS, A. 354, 488
PRADELLE-PLASSE, N. 315
PRADES, G. 512
PRATTEN, J. 398
PRECHTL, C. 534
PREIS, V. 302
PREUS, H. 287
PROCTOR, G. 386
PROENA, L. 74, 136, 140, 213, 241, 405, 472, 477
PROFETA, I. 409
PROKSCH, S. 328
PRSKALO, K. 246
PRUCKSATHAMRONGKUL, W. 497
PUTZGER, J. 51
Q
QUARANTA, A. 481
QUIRYNEN, M. 491, 498, 538
R
RAAB, B. 534
RAAB, W. H.-M. 17, 48, 525
RACZ, G. 390
RADI, S. 415
RADICS, T. 248
RADNAI, M. 46, 210
RADOVIC, I. 372
RADOVIC, S. 50
RAHIOTIS, C. 520
RAIA, G. 305, 430
RAKONCZAY, Z. 108, 406, 423, 507
RAMMELSBERG, P. 293, 414
RAMOS, J. C. 55
RAMOS-TORRECILLAS, J. 102
RANGEL, J. 405
RASK, Z. 176, 531
RAYNAL, J. 513
REBOUSSIN, A. 343
RECHMANN, P. 550
RECLARU, L. 510
REDL, P. 255
REIBEL, J. 138
REICH, S. 155
REICHERT, S. 326, 335
REICHERT, Y. 335
REICHL, F. X. 543
REIG, C. 427
REINBOTH, A. 217
REIS, J. 241
REISE, M. 542
REMPORT, B. 499
RENCZ, B. 499
RENGO, C. 262
RENGO, S. 63, 408, 410
RENOUD, P. 343
RHEINBERGER, V. 431
RIBEYRON, C. 315
RICCITIELLO, F. 63
RICHLING, E. 107
RICHTER, I. 221
RICHTER, S. 174, 195, 233
RINTAKOSKI, K. 93
RIOU, P. 513
RIST, K. 426
RIVIECCIO, V. 408, 410
RODRGUEZ, J. 47
RODRIGUEZ, P. A. 40
ROGANOVIC, J. 169
ROGGENDORF, H. C. 496
ROGGENDORF, M. J. 496
ROJANAWATSIRIVEJ, S. 483
RLLEKE, C. 73
ROMN RODRGUEZ, J. L. 118, 292, 299
ROMAN, A. 240
ROMN, J. L. 291
ROMER, J. 234
ROMINU, M. 240
ROSENTRITT, M. 297, 300, 301, 302, 376, 511, 515
ROSIVALL, L. 269
ROUAS, A. 493
ROZAN, C. 241
ROZGAJ, R. 409
RZSA, N. 45, 462, 505
RUETTERMANN, S. 17, 525
RUIZ, C. 102
RUMPHORST, A. 221
RUSSO, E. M. A. 363
RUSU, D. 56, 270
RUSU, L. C. 510
S
SAAD, S. 144, 460
SAADI-THIERS, K. 537
SAARINEN, A. 139
SAARINEN, A. M. J. 281
SABBAGH, J. 232
SABBAH, W. 81
SMUNDSSON, S. R. 352
SAFAR, A. M. A. 274
SFR, O. 104
SAID-AL-NAIEF, N. 483
SAITO, W. 469
SAITOH, J. 97
SAITOH, K. 25
SAKAGAMI, H. 97, 98, 101
SAKAMOTO, M. 469
SAKUMA, S. 94, 95, 96, 490
SAKUMA, T. 420
SALEHI, H. 43
SALVI, G. 141, 336
SALZ, U. 426, 439
SNCHEZ-BELTRN, M. C. 541
SNDOR, B. 132, 358
SNDOR, J. 463
SANGGARNJANAVANICH, S. 277
SANO, H. 215, 361
SANSANEEYAWAT, K. 435
SANTOS, J. M. 55
SANZ, M. 385, 541
SAR SANCAKLI, H. 247
SARANG, Z. 152
SARBU, C. 56
SARI, Z. 145
SARIRI, K. 18, 24
SARRAZY, B. 492
SATO, T. 504
SATOH, M. 57
SAVANHEIMO, N. 89
SAVEANU, C. I. 223
SAVIC STANKOVIC, T. 314
SAWADA, N. 273
SCHFER, C. 326
SCHALLER, H. G. 216, 217, 326, 335, 445
SCHARA, R. 179
SCHECHNER, G. 305
SCHILLE, C. 303
SCHINDLER, H. J. 39, 546
SCHLEGEL, K. A. 534
SCHLIEKMANN, C. 302
SCHMALZ, G. 18, 51, 212, 523
SCHMALZL, A. 306, 307
SCHMIDLIN, P. R. 44, 295, 362
SCHMITTER, M. 39, 546
SCHNABELRAUCH, M. 542
SCHNAIDT, U. 330
SCHNUR, T. 426
SCHULZ, S. 326, 335
SCHULZ, S. D. 370, 522
SCHWARZ, F. 383, 421
SCHWARZ, U. 328
SCHWARZTMANN, P. 333
SCHWEIKL, H. 523
SCOTTI, R. 371
SCULEAN, A. 56, 141, 268, 270, 329, 336
SCULLY, C. 348
SCH, A. C. 414
SECILMIS, A. 518
SECRET, E. 54
SEDDA, M. 72, 308
SEEMANN, R. 205, 206, 511
SEGATTO, A. 526
SEGATTO, E. 526
SELVA, E. J. 413
SEN, D. 70, 437, 438
SENER, B. 44
SERENO, N. 515
SERES, L. 355
SERA, I. 179
STL, G. 327
SEYAM, R. 242
SEZGIN, Y. 253, 278
SEZINANDO, A. 321
SHALABY, H. 20
SHEIHAM, A. 81
SHIBATA, T. 273
SHIMADA, J. 97
SHIMIZU, T. 16, 487
SHIN, H. I. 483
SHINDO, T. 448
SHRESTHA, A. 28
SIEGEL, M. 13
SIEGMUND, S. 216
SIERRA, L. 40
SIGUSCH, B. 542
SILAGHI-DUMITRESCU, L. 41
SILIKAS, N. 366
SILVA, G. 74
SILVRIO, S. R. 241
SIMEON, P. 87, 441
SIMOES, I. 225
SIMON, I. 45, 505
SIMONIS, P. 537
SINCA, A. 172
SINIAWSKA, J. 449
SIRIVANICHSUNTORN, P. 485
SKAARE, A. B. 85, 86
SKALERI, U. 179
SKOPK, B. 114
SKOVBJERG, H. 479
SKRTIC, D. 18
SKLADTTIR, H. 352
SLANGEN, P. 513
SLEZK, S. 286
SOANCA, A. 240
SDER, B. 139, 142, 143, 281
157
SDER, P. . 139, 142, 143, 281
SOFFER, E. 263
SOL RUZ, M. F. 118, 292, 299
SOL, F. 219, 291, 427
SOLA, M. F. 413
SOLDO, M. 87
SOS, B. 337, 530
SOOS, S. 279
SORSA, T. 143, 289
SOSSI, D. 375, 380, 381
SOUDAN, M. 333
SOUHAID, P. 232
SOVIC, I. 18, 24
SPAGNUOLO, G. 63
SPAGNUOLO, G. 408, 410, 523
SPARING, K. 445
SPIDLEN, M. 442
SPRATT, D. 397
STAMATOVA, I. 79
STAQUET, M. J. 199
STASINOPOULOU, I. 251
STAWARCZYK, B. 362
STECHER, U. 517
STEFANOVA, V. 79
STEFNSSON, G. 486
STEIGER, M. 302
STEIN, J. M. 335
STEINBACH, P. 505
STEINBERG, T. 328, 370, 522
STEINHAUS, J. 15, 317, 376
STEINHOFF, G. 272
STELLA, M. 380
STENDER, E. 159
STERER, N. 99
STERNBERG, K. 475
STERZENBACH, G. 192, 250, 511
STEWARD, M. C. 392
STIEDL, P. 337, 530
STIESCH, M. 330, 475
STIMMELMAYR, M. 157
STOBER, T. 414
STOJANAC, I. L. 62
STOJI, D. M. 357
STOJIC, D. 169
STOPA, J. 449
STRATUL, S. I. 56, 270
STRUILLOU, X. 324
STRUJIC, M. 290
STRUYS, T. 200
STUBER, I. 137, 269, 501
STUMPP, S. N. 330, 475
SUBARNBHESAJ, A. 483
SUBASI, M. G. 66, 117
SUBBALEKHA, K. 484, 485
SUENAGA, S. 504
SUGARS, R. 167
SUGIHARA, K. 504
SULYOK, L. 112
SMEGI, B. 316
SUNDBERG, S. A. 89
SUOMINEN, A. L. 90
SURKIN, P. N. 266
SUYAMA, Y. 123, 125, 189, 215, 359, 360
SUZUKI, K. 124
SUZUKI, T. 16
SWIFT, E. J. 129
SZ
SZAB, A. 503, 507
SZABO, B. T. 177
SZAB, G. 84, 170, 327, 503, 507, 529
SZAB, Z. 391
SZALAI, C. 530
SZALAI, E. 285
SZALMA, J. 316, 327, 391
SZALKI, M. 23
SZNT, I. 132, 358, 530
SZEBERNYI, J. 327
SZEKELY, A. D. 351
SZKELY, M. 38
SZEKELY, T. 248
SZNSI, R. 423
SZENDRI-KISS, D. 329
SZENTANDRSSY, N. 503
SZENTPTERY, A. 170
SZEPESI, M. 261
SZIGETI, K. 113
SZILAGYI, L. 178
SZONDY, Z. 152
T
TAHMISCIJA, I. 50
TAIRA, H. 273
TAKAHASHI, Y. 57
TAKTSY, A. 316, 391
TAKEUCHI, R. 100, 494
TAMURA, N. 97
TANAKA, T. 361, 448
TANER, L. 253, 278
TANIC, N. 169
TAR, I. 478
TARJN, I. 45, 462, 499, 505, 530
TARLE, Z. 409
TARLE, Z. 18, 24, 246
TASCHNER, M. 250
TASSERY, H. 43, 551, 554
TAUBCK, T. T. 295
TAVARES, V. 321
TCACENCU, I. 252
TELLEFSEN, G. 310
TEMESI, G. 530
TENENBAUM, H. 181, 323, 537
TENNERT, C. 489
TERANAKA, T. 16, 447, 448, 487
TERVAHARTIALA, T. 143
TERZIS, G. 265
TEUGHELS, W. 538
THABUIS, C. 444
THALACKER, C. 218, 221
THAMRONGANANSKUL, N. 432, 433, 434, 435
THEELKE, B. 306, 307
THIESSEN, D. 234
THOSAPORN, W. 483
TIAN, K. 158
TIERS, L. 110
TILLY, P. 537
TING, S. 361
TOBIAS, E. 53
TOLDI, J. 108
TOLIDIS, K. 220
TOMA, C. 276, 464
TOMA, S. 536
TOMAKIDI, P. 328, 370
TOMOMURA, A. 101
TOMOMURA, M. 101
TOMONAGA, M. 469
TOMOV, G. 79
TORNOR, W. 434
TOROK, B. 334
TTH, V. 500
TTH, Z. 42, 112, 530
TOUMBA, K. J. 311
TOUR, G. 252
TRAMINI, P. 26, 27, 65
TRANUS, S. 127
TRIMMEL, B. 530
TRIPHAN, M. 535
TROVIK, T. A. 461
TRZASKAWKA, E. 110
TSEVEENJAV, B. 90
TSURUTA, S. 57
TUCKER, A. S. 528
TUMRASVIN, W. 451
TUNDEMIR, A. R. 156
TUNCELLI, B. 437, 438
TUNCER, B. 539
TUNJAN, R. 511
TURP, I. 417
TURP, V. 70, 437, 438
TRY, F. 83, 456
TURZO, K. 46, 108, 339, 406, 423, 507
TUZUNSOY-AKTAS, R. 184
TVEIT, A. B. 85, 86
TYAGI, K. 443
TZANOVA, S. 79
TZIAFA, C. 368
U
UGAKI, Y. 257, 258
UITTO, V. J. 476
ULBERT, I. 53
ULKE, D. 418
UMPRONSIRIRAT, S. 433
UNGVRI, K. 406, 423
UNGVRI, T. 463
UNLU, N. 313
URAZ, A. 253, 278, 539
URBAN, I. 384, 549
URBAN, M. 307
URQUHART, D. 468
USUMEZ, A. 518
UTTERODT, A. 347
UYGUN, M. E. 145
UZUKA, S. 130
V
VACHEY, E. 508
VALCARCEL, J. 27
VALCEANU, A. S. 14
VALENTE, T. 55
VALENTIC-PERUZOVIC, M. 36
VALLETTA, R. 262
VAN DEN STEEN, P. 123
VAN DENVELDE, S. 491, 498
VAN DIJKEN, J. W. V. 193
VAN ENDE, A. 125, 161, 162, 318
VAN LANDUYT, K. 124, 197
VAN LANDUYT, K. L. 160, 161, 162, 363, 521
VAN MEERBEEK, B. 120, 123, 124, 125, 160, 161, 162, 189,
197, 215, 318, 342, 359, 360, 363, 371, 521
VANTORNOUT, M. 498
VANTOURNOUT, M. 491
VANCAUWENBERGHE, F. 491, 498
VARGA, E. 176, 176, 500, 531, 531
VARGA, G. 38, 42, 104, 111, 112, 151, 180, 337, 351, 390,
392, 530
VARGA, I. 105
VARGA, J. 506
VARGA, R. 151
VARGA, T. 46
VASSILIADIS, L. 244
VECSERNYS, M. 261
VEGH, A. 8, 526, 532
VEHKALAHTI, M. M. 89, 90
VENANCIO, F. 30, 31
VENUGOPALAN, S. 527
VERDE, P. 454
VICHI, A. 72, 243, 308
VIDISDOTTIR, S. R. 174
VIEIRA FERREIRA, L. F. 11
VILLAT, C. 315
VINAY, N. 26
VIRTANEN, J. I. 89
VISCONTI, L. 33, 34
VISKIC, J. 290
VISSINK, A. 388
VIVAN CARDOSO, M. 161
VIZI, S. 10
VLADIMIROV, B. 5
VLADIMIROV, S. 239
VODANOVIC, M. 29
VOLK, J. 369, 407
VORDERMARK, D. 445
VOZZA, I. 481
VUKOVIC, Z. 374
VURAL, F. 183
VURAL, H. 288
158
W
WAHA, C. 523
WAHL, I. 407
WALBOOMERS, F. 165
WALLBACH, J. 304
WALTER, H. 60
WANG, J. 527
WANG, X. 444
WANGSRI, S. 484
WANING, A. 188
WARKENTIN, M. 319
WATANABE, A. 469
WATANABE, I. 340
WATANABE, S. 469
WATTS, D. 344, 542
WATZEK, G. 9
WATZKE, R. 237, 238, 404
WEGE, K. C. 293
WEGEHAUPT, F. J. 44, 325
WEIGL, P. 403
WEISEL, T. 534
WENCKERT ANDERSSON, I. 446
WENDEL, M. 252
WIDSTRM, E. 353
WIEDIG, C. 430
WIEGAND, A. 325, 362
WIELAND, M. 221
WIKESJ, U. M. 164
WILKOSKI, W. 58
WILLERSHAUSEN, B. 159
WIMMER, G. 211
WINDISCH, P. 329, 334, 336, 382
WOLFART, S. 155
WOLKEWITZ, M. 119
WOLLENWEBER, N. 495
WOOD, D. J. 515
WRBAS, K. 489
WYRWA, R. 542
Y
YACHOUH, J. 5
YAEGAKI, K. 146
YAKOB, M. 139, 142, 143
YALCIN CAKIR, F. 502
YALIM, M. 253
YALM, M. 278
YAMADA, T. 359
YAMAGUCHI, M. 448
YAMAGUCHI, S. 16
YAMAGUCHI, T. 277
YAMAN, D. 183
YANG, J. 443, 452, 467
YASHIRO, Y. 277
YASUTAKE, A. 57
YAVUZ, T. 229, 373
YEGIN, C. 230
YESILYURT, C. 367
YILDIZ, E. 19, 247
YILMAZ, H. R. 288
YNDEM, I. 71
YONDEM, I. 121
YOSHIDA, Y. 124, 160, 342
YOSHIHARA, K. 124, 160, 189, 521
YOSHII, S. 81
YOSHINO, N. 487
YU, C. H. 482
YUCEL, M. T. 69, 121
YUCEL-LINDBERG, T. 393, 544, 545
YUHARA, K. 98
Z
ZAHARIA, A. 109
ZALAI, Z. 22, 88
ZAMBON, J. 473
ZAMBON, J. J. 429, 474
ZANGER, K. 48
ZASLANSKY, P. 13, 21
ZEIN ELABDEEN, H. R. 280
ZELJEZIC, D. 409
ZELLES, T. 92, 113, 114, 458
ZERGUINE, R. L. 218
ZICARI, F. 371
ZIMMER, S. 60, 453, 454, 495
ZINELIS, S. 154, 366, 379, 519, 520
ZOLNAI, V. 52
ZOR, E. 282
ZSOLDOS, G. M. 112
ZUCH, T. 157
ZWINGE, S. 157
ZYLINSKI, M. 542
159
160
A
Acceptance 88, 425
Acid etch 53, 197, 217, 229, 237, 361, 438
Acids 44
Acrylics 408, 412
Add/adhd 352
Adherence and colonization 17, 136, 270, 429, 471,
475, 477, 525
Adhesion 20, 56, 60, 104, 116, 118, 122, 124, 125, 126,
193, 194, 197, 214, 215, 216, 217, 218, 221, 222, 229, 230,
241, 243, 260, 292, 359, 360, 361, 362, 363, 367, 372, 378,
420, 426, 430, 437, 438, 439, 440
Adhesive composite 232
Adhesive dentistry 188
Adhesive syytem 189
Adolescence 85, 87, 109, 112, 174, 453, 454, 457, 539
Adult population 90
AFM 121
Age estimation 174
Agenesis 38
Aggregating factors 471
Aggressive periodontitis 280
Aging 19, 241, 306, 307
Alcohol 93
All-in-one system 361
Alloys 62, 366, 379, 406, 510, 519
Amalgams 57, 445
Ameloblastoma 483
Amines 491, 498
Amorphous calcium-phosphate 18
Anatomy 176, 341, 499
Anchorage 8
Anesthetics 100, 357, 494, 503, 505
Angiogenesis, lymphangiogenesis 50
Animal 2, 9, 57, 113, 257, 283, 320, 323, 324, 342, 351,
421, 469, 534, 537, 545
Anthropology 29, 45
Antigens-antibodies 50, 108
Antimicrobial agents/inhibitors 61, 99, 103, 115, 135,
180, 216, 312, 394, 466, 468, 470, 473, 475, 541
Antioxidant micronutrients 186
Antiseptics 56, 98, 103, 135, 275, 284, 497
Anxiety 76, 77, 492
Apex locator 358
Apex locators 508
Apical coronal 59
APL 263
Apoptosis 97, 98, 522
Assessment 88, 310, 502
B
Bacterial 17, 103, 135, 429, 466, 469, 471, 476, 477, 525
Behavioral science 78, 88, 170, 276, 461, 464
Bioactivity 2, 265
Biochemistry 331, 391, 415, 447, 527, 540
Biocompatibility 339, 343, 369, 407, 408, 409, 411, 423,
487
Bioengineering 324, 328
Biofilm 17, 144, 180, 270, 275, 443, 460, 475, 489, 525,
538, 541
Biomaterials 6, 7, 14, 54, 158, 165, 214, 223, 252, 261,
263, 265, 268, 312, 315, 324, 339, 359, 407, 421, 428, 487,
523
Biomechanics 34, 35, 67, 176, 251, 256, 371, 428, 531
Biophysics 508
Biostatistic 400
Bisphenol a 411
Bleach 41, 46, 150, 225, 227, 228, 229, 231, 378, 409
Blood 51, 142, 331, 335, 351, 540
Body temperature 21
Bone 9, 102, 147, 176, 177, 179, 203, 263, 266, 283, 320,
338, 341, 342, 424, 428, 529, 533, 534, 545
Bone repair 40, 102, 151, 252, 262, 342
Bruxchecker 480
Bruxism 93, 254, 256, 480, 546
C
CAD/CAM 70, 72, 121, 155, 157, 238, 296, 297, 300, 301,
304, 305, 308, 402, 427, 512, 513, 517, 531
Capsaicin 48
Carbamide peroxide 41
Carcinogenesis 132, 257, 258, 484, 535
Cardiovascular disease 208, 209, 281, 330, 455, 537
Caries 27, 80, 81, 82, 108, 127, 140, 196, 204, 312, 352,
441, 442, 446, 448, 449, 456, 479, 553, 554
Cariology 22, 90, 127, 137, 325, 443, 444, 445, 446, 447,
448, 495
Castings 73, 518, 520
Cathelicidin 273
Cell biology 54, 102, 181, 327, 328, 333, 407
Cell culture 104, 203, 339, 343, 423, 467, 487, 523, 543
Cements 1, 2, 4, 116, 118, 120, 155, 158, 159, 197, 230,
241, 243, 245, 247, 250, 298, 374, 405, 426, 430, 431, 432,
433, 434, 435, 440
Central nervous system/peripheral nervous system
114, 458
Cephalometric analysis 25, 36, 145, 149
Ceramics 65, 66, 69, 71, 72, 116, 117, 118, 119, 120, 121,
154, 155, 159, 197, 219, 226, 227, 228, 235, 238, 245, 265,
290, 291, 292, 293, 297, 298, 299, 300, 301, 302, 303, 305,
306, 308, 365, 406, 448, 511, 512, 513, 520
Cerium chloride 44
Cervical lesion 363
Chaillet's scores 29
Characteristics 7, 419
Chemical 124, 257, 487
Chemistry 106, 107, 257
Chemotaxis 104, 201
Children 29, 30, 31, 100, 108, 115, 174, 313, 352, 353,
461, 505
Chlorhexidine 58
Chlorine-dioxide 470
Chromatography 405
Class III 145
Cleft lip-palate 26, 27, 260
Clinical training 492
Clinical trials 36, 183, 194, 195, 196, 198, 231, 232, 237,
238, 239, 240, 285, 293, 294, 298, 329, 363, 364, 413, 414,
444, 449, 454, 473, 474, 495, 496, 497, 532
Cold plasma 246
Color 11, 69, 71, 129, 156, 228, 305, 433, 436, 491, 498
Compomer 449
Composite bonding-system 191
Composite repair 377
Composites 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22,
23, 24, 119, 120, 123, 125, 193, 194, 195, 196, 198, 214,
215, 216, 226, 227, 232, 234, 235, 237, 239, 240, 242, 243,
250, 295, 314, 315, 316, 317, 318, 319, 344, 345, 346, 347,
363, 368, 369, 370, 372, 374, 376, 377, 380, 381, 411, 430,
432, 434, 435, 436, 449, 521, 522, 523, 525
Computer, intraseptal 357
Computers 176, 178, 304, 531
Conductivity 508
Condyle 147
Connective tissue 283
COPD 279
Corrosion 63, 510, 519, 524
Cost 501
Cotinine 109
Creep 220
Crevicular fluid 110, 143, 184, 286, 539
Cross-professional 526
Cryotherapy 482
Crystallinity 307
CT, MRI 296
Curing behaviour 317
Curing depth 376
Curing lights 15, 20, 23, 65, 141, 314, 316, 376
Cycle fatigue 62
Cysts 355
Cytokine 134, 203, 335, 488, 537, 539
D
Decision-making 88
Delivery systems 104, 261, 286, 357, 394, 465
Demineralization/Remineralization 18, 42, 311, 322,
441, 445
Dental adhesives 160, 161, 162
Dental follicle 272
Dental materials 4, 11, 12, 13, 15, 16, 17, 18, 19, 21, 57,
60, 61, 65, 116, 118, 119, 124, 125, 126, 154, 157, 159,
193, 194, 196, 197, 198, 205, 206, 207, 213, 218, 221, 223,
224, 225, 230, 233, 234, 236, 237, 238, 240, 241, 244, 246,
247, 249, 250, 261, 262, 264, 297, 298, 299, 300, 301, 302,
305, 308, 314, 316, 317, 318, 343, 360, 365, 366, 367, 369,
370, 372, 374, 376, 377, 380, 381, 406, 408, 410, 411, 412,
418, 419, 426, 430, 431, 437, 438, 439, 440, 448, 487, 513,
515, 516, 520, 522, 523, 525, 542
Dental students 74
Dental-treatment, paraoxonase 455
Dentifrices 144, 153, 284, 452, 466, 468
Dentin 1, 3, 4, 43, 44, 48, 53, 126, 153, 159, 202, 213, 216,
217, 219, 222, 236, 312, 321, 359, 360, 361, 368, 420, 445,
489
Dentin bonding agents 123, 124, 125, 193, 195, 213,
214, 216, 217, 218, 220, 221, 222, 224, 234, 237, 239, 360,
362, 363, 364, 367, 372, 377, 410, 419, 430, 432, 437, 438
Dentin fluid 53
Dentin fluorescence 552
Denture adhesive 171
Denture adhesives 417
Diabetes 92, 169, 271, 285, 457, 540
Diagnosis 39, 75, 110, 127, 128, 258, 332, 356, 424, 480,
486, 491, 495, 498, 508
Diet 84, 325
Digital image analysis 113, 117, 177, 178, 247, 314, 341,
416, 506, 526, 531
Digital impression 70
Double crowns 514
Dysplasia 482
E
Ecology 469
Economics 22, 168
Education research 78, 129, 130, 131, 492
Effectiveness 100, 313, 361, 427, 494
Elasticity 33, 47, 220, 319
Elastomers 33
Electroforming 520
Ellipsometry 46
EMG 546
Enamel 12, 41, 42, 46, 47, 126, 137, 150, 152, 166, 213,
223, 225, 230, 311, 325, 359, 362, 378, 418, 441
Endodontic sealer 60
Endodontics 40, 55, 58, 61, 62, 128, 135, 178, 235, 244,
358, 373, 375, 500, 506, 543
Enzymes 123, 152, 181, 288
Epidemiology 80, 81, 82, 84, 85, 90, 93, 112, 173, 255,
267, 281, 353, 356, 450, 507
Epigingivaltm tissue 452
Epithelial biology 390, 476, 484
Epithelium/epithelial 146, 269, 283, 392, 406, 527
Erosion 42, 85, 86, 112, 309, 311, 325, 356
Esthetics 68, 69, 129, 172, 290, 292, 293
Ethanol-wet bonding 367
Evaluation 100, 130, 233, 422, 493, 494, 502
Evidence-based dentistry 175
Exercise 86
Expert system 91
Extracellular matrix molecules 184, 392
F
Facemask 148
Ferrule effect 371
Fiber post 190, 250
Fiber posts 245
KEYWORDINDEX
Fiber-reinforced composites 243, 244, 246, 247, 249,
371, 511
Fibroblasts 277, 327, 340, 393, 408, 544
Finite analysis 251, 412
Fluorescence 554
Fluoride 106, 107, 153, 222, 236, 311, 322, 418, 419, 420,
442, 443
Fluoride-uptake 441
Flurorescence 550
FMRI 254
Formation 48, 166, 530
Fracture toughness 318
Function 25, 30, 31, 67, 113, 114, 509, 529, 546
Functional foods 396, 397, 398
Fungi 479
G
Gene expression 28, 49, 101, 169, 199, 264, 333, 370,
390, 393, 407, 527, 544
Gene polymorphism 488
Gene therapy 390
General anesthesia 89
General practice 233
Genetics 274, 285, 337, 484, 485, 530
Gerontology 496
Gingival recession 547
Gingival recessions 183
Gingival retraction 184
Gingival tissue 335
Gingivitis 269, 282, 284, 289, 454
Glass ionomers 14, 158, 163, 248, 420
Glycoproteins 270
Grafts 549
Graphology 76
Growth & development 28, 29, 32, 38, 102, 174, 203,
261, 499, 526, 528, 529, 530
Gtr, Er:YAG 329
H
H&N cancer 294
Halitosis 99, 144, 284, 350, 460, 473, 474, 491, 498, 507
Halotosis 348
Hardness 15, 19, 24, 47, 225, 375
Health services research 80, 89, 168, 356
Heat-shock-protein 389
Histology - ultrastructure 48, 114, 200
HIV infection 453
Home care 459, 496
Hormones and growth factors 97, 333
Host-microbial interactions 143, 180
HPLC 522
Human 22, 42, 76, 77, 94, 95, 96, 100, 106, 107, 111, 179,
193, 198, 258, 267, 277, 287, 330, 331, 337, 409, 416, 450,
490, 494
Hydrogen peroxide 150
Hypertrophy/hyperplasia 113
I
Image analysis 39
Immature roots 242
Immune response 138, 199, 452, 467, 524
Immunology 8, 134, 138, 286, 467
Impedance 519
Implantology 6, 179, 259, 301, 332, 334, 339, 343, 383,
384, 385, 401, 402, 403, 404, 421, 423, 424, 425, 426, 428,
475, 509, 534, 536
Implants 6, 7, 9, 37, 151, 264, 332, 338, 340, 341, 342,
343, 413, 424, 427, 429, 511, 512
Impression materials 70, 427
Indirect restorations 198
Infection 103, 139, 181, 182, 330, 465, 475, 489
Inflammation 50, 92, 134, 138, 142, 180, 181, 252, 266,
271, 273, 279, 285, 323, 335, 393, 394, 452, 457, 467, 544,
545
Inflammatory mediators 101, 142, 143, 184, 199, 272,
327, 393, 455, 457, 544
Infraocclusion 462
Inlays 240
Instrumentation 500
Interdisciplinary 290, 412
Interfaces 66, 119, 125, 223, 365, 367, 506
J
Joint dysfunction 75, 528
K
Keratinocytes 370
L
Laser-fluorescence device 553
Lasers 6, 117, 121, 223, 224, 226, 227, 329, 339, 423, 429,
481, 489, 501, 518
Learning 130, 131
LFN, EDS 321
Lighttransmission 157
Line-1 484
Lipids 455
Loading 230, 242, 248, 251, 299, 300, 302, 319, 320, 371,
431, 512, 513, 515, 524
M
Magnetic Resonance Imaging 179
Magnification loupes 502
Malocclusion 30, 31, 32, 36, 45, 148, 149, 529
Marginal fit 66
Mass spectrometry 132
Mastication 12, 39, 297, 302, 490, 509, 515
Median, mandible 355
Mercury 57
Mesenchymal-stem cells 338
Metals 6, 63, 66, 516, 518, 524
Methodology 151, 310, 468, 493
Micro CT 177
Micro-CT, pro-taper 506
Microabrasion 322
Microbiology 105, 135, 140, 141, 144, 181, 271, 429,
460, 466, 468, 471, 473, 479, 538
Microinvasive treatment 137
Microleakage 58, 59, 196, 214, 219, 224, 247, 377, 434
Micronucleus test 409
Mineralization 29, 152, 202, 324, 369, 442
Miniscrews 320
Minority 77
Missing teeth 37
MMP 123
MMPS 122
Molecular adsorption 7
Molecular biology 49, 333, 337, 393, 484, 530
Motivation 84, 87, 88, 172
Mouthrinses 99, 153, 275, 284, 287, 311, 322, 442, 454,
460, 473, 474, 541
MTA 375
Mucoepidermoid carcinoma 485
Mucosal diseases 425, 465, 478
Multiple-torque 35
Muscle 176, 546
Myocardial infarction 281
N
Nano-dust 521
Nanoparticles 312
Nasoalveolar molding 260
Near-infrared spectroscopy 94, 95, 96
Necrosis 533
Neoplasia 133, 255
Neuronal 28, 92
Neuroscience 53, 94, 95, 96, 256, 546
Neutron scattering 158
Neutrophils 331, 476, 540
Non-candida albicans 472
Non-linear optical-microscopy 551
Nutrition 444, 456
O
o-Cymen-5-ol 467
Occlusion 32, 34, 67, 75, 291, 295
Ocular torticollis 32
Odontoblasts 199
Oral biology 26, 38, 108, 262, 273, 331, 351, 447, 474,
540
Oral health 353, 395, 463
Oral hygiene 56, 74, 83, 84, 87, 90, 91, 115, 140, 287,
291, 313, 397, 398, 450, 456, 477, 496
Oral malodour 349
Oral medicine 98, 138, 139, 354, 453, 478, 479, 481, 486,
507
Oral microflora 185
Oral mucosa 258, 269, 443, 452, 458, 472, 481, 482
Oral surgery 332, 391, 422, 531, 532, 533
Orthodontic extrusion 290, 536
Orthodontics 8, 25, 30, 31, 32, 33, 34, 35, 37, 145, 147,
148, 149, 173, 229, 320, 442, 462, 524, 526, 528, 532, 536,
539
Orthopedics 145, 526, 532
Osteoblasts/osteoclasts 102, 151, 263, 264, 333, 423,
534
Otalgia 75
Outcome (Health) 497
Overdenture 413
Ozone 446
P
Pain 236, 259, 490, 505
Palate 527
Pathology 133, 255, 354
PDL cells 543
Pedodontics 45, 80, 224, 352, 462, 497, 505
Peri-implant disease 332
Periodontal disease 56, 90, 139, 143, 180, 183, 208, 209,
210, 211, 251, 267, 274, 279, 281, 288, 323, 329, 337, 466,
501, 507, 537, 538, 541, 542, 545
Periodontal organisms 139, 141, 143, 182, 208, 275,
280, 282, 326, 330, 474, 537, 538, 541
Periodontics 56, 91, 142, 183, 203, 266, 268, 270, 273,
274, 275, 276, 286, 288, 290, 323, 330, 334, 335, 336, 337,
382, 457, 507, 539, 547, 548
Periodontium-gingiva 182, 265, 269, 271, 279, 283, 285,
288, 327, 328, 351, 382, 476, 547, 548
Pharmacology 97, 101, 394, 465
Photo-acoustic stimulation 111
Physical 13, 16, 73, 159, 221, 315, 426, 431
Physiology 254, 266
Plaque 74, 142, 280, 287, 289, 444, 469
Plaque control 187
Plaque fluid 282, 538
Plaque index 87
Police student 456
Polishing paste 380
Polishing, roughness 156
Polymerization 15, 18, 21, 23, 24, 65, 271, 314, 316, 317,
376, 431
Polymerization-shrinkage 194
Polymers 16, 20, 23, 58, 157, 315, 316, 405, 411, 415,
515, 516
Polysaccharides 101, 342
Porcelain systems 71, 119, 156, 292, 308
Porosity 374
Post-operative sensitivity 239
Pregnancy 282, 289
Premalignant lesions 478
Premature birth 210, 211
Preparation 304
Preschool children 82
Press technology 238
Preventive dentistry 27, 45, 78, 287, 310, 313, 352, 395,
454, 461, 464
PRF 253, 278
Program 130
Prophylaxis 115, 137, 418, 477
Prostheses 73, 155, 171, 219, 294, 299, 412, 413, 416,
417, 422, 428, 463, 509, 512
161
Prosthodontics 13, 65, 67, 70, 73, 117, 118, 157, 171, 175,
184, 227, 228, 235, 241, 245, 248, 291, 292, 293, 294, 295,
297, 298, 299, 300, 301, 304, 334, 365, 373, 379, 403, 414,
415, 416, 417, 427, 439, 440, 462, 463, 472, 477, 509, 513,
514, 515, 518
Protease 123
Proteins 110, 111, 132, 257, 386, 391, 447, 534, 535
Proteomics 535
Psychology 83, 172, 450
Psychophysics 129
Public health 80
Pulp 3, 5, 48, 50, 51, 52, 55, 199, 200, 201, 202
Pulp cells 410
Pulpal disease 369
Pulpal pressure 222
Pulpectomy 497
Push-out bond-strength 244
Q
Quality assurance 131, 502
Quality of life 84, 170, 294, 413, 425, 450, 451, 453
Questionnaire, psychometric properties 68
R
Radiation 341
Radiology 133, 177, 178, 213, 358, 445, 499, 500, 501
Raman microscopy 365
Recharge ability 419
Regeneration 9, 40, 51, 54, 55, 164, 165, 166, 182, 201,
265, 268, 272, 277, 329, 392, 536, 548
Regenerative medicine 49
Remission rate 11
Resin cement 192
Resin cements 437
Resin infiltrant 362
Resorption 134, 323, 499, 545
Restorative materials 204
Risk factors 309
Root 40, 60, 178, 245, 270, 358, 500
Root canal fillings 58, 59, 60, 61, 64, 358, 373, 543
Roughness,orthodonticbrackets 516
RPD 414
Rubber points 381
S
Saliva 86, 99, 106, 107, 108, 110, 111, 112, 114, 115, 132,
139, 289, 313, 386, 387, 389, 391, 405, 439, 447, 465, 479,
486, 491, 498, 535
Salivary dysfunction 354, 391, 392, 486
Salivary glands 104, 110, 113, 114, 138, 169, 171, 266,
269, 351, 354, 388, 390, 458, 485, 486
Satisfaction 168
Scintigraphy, transporter 504
Sealants 64, 217, 232
Secretion 111, 171, 390
Sedation 505
Self etch 229
Self-adhering resin 368
Self-identity 459
Semaphorin 3A 28
Serum-plasma 288
Shrinkage 24
Silorane 195
Sjgren's syndrome 388
Soft-tissue 149
Sports drinks 19
Stain 11, 220
Statistical analysis 399
Stem cell 54, 324
Stem cells 146, 167, 182, 200, 201, 202, 328
Streptococcus mutans 136, 140
Stress 13, 20, 23, 76, 77, 220, 251, 302, 308, 319, 387, 480
Structure 46, 63, 154, 177, 510, 517
Students, dentists 79
Surfaces 7, 41, 63, 116, 117, 121, 154, 226, 258, 303, 307,
379, 380, 381, 415, 448, 514
Surgery 40, 336
Survey 295
Survival analysis 155
Syndrome 528
Synovial fluid 326
Systematic review 175, 235, 291
T
Talon cusp 45
Taxonomy 469
Technology 53, 130, 131, 501
Teeth 28, 38, 55, 174, 256, 319, 527
Tenascin-C 354
Therapeutics 97, 533
Thermocycling 215
Tissue engineering 5, 55, 201, 252, 261, 277, 328, 392
Tissue or organ culture 52, 97, 98, 101, 286, 406
Titanium 340
TMJ 173
TMJ and masticatory muscles 30, 31, 36, 67, 254, 490,
528, 529
Tobacco 78, 91, 109, 255, 274, 279
Tongue 25, 92, 140, 144, 458, 460
Tooth agenesis 530
Tooth reinforcement 420
Tooth-whitening, spectrophotometer 231
Toothbrushes 91, 310, 461, 496
Toughness 47
Toxicology 98, 106, 107, 410, 543
Toxins 272
Translucency 72
Treatment requests 172
Tribochemical coatings 366
U
Ultrasound/sonics 219
Utilization/demand 89
V
Vickers 225
Visual acuity 131
W
Wear 12, 16, 295, 303, 307, 310, 415, 514
Wound healing 146, 202, 268, 533
Y
Young health 83
Z
Zirconia 120, 306
162